Kristalliserings försök med TGG5 och mutant studier av TGG4
myrosinase från backtrav (Arabidopsis thaliana) by Sibrian, Carlos
 1 
 
EX0421 independent project/degree project in biology E, 30 
Masters thesis, 2009 
Master programme in biology 
ISSN 1651-5196 Nr 105 
 
 
 
 
 
 
Crystallization attempt of TGG5 and 
mutant studies of TGG4 myrosinase from 
thale cress (Arabidopsis thaliana) 
 
             
                                  http://hfspmetabolomics.life.uiuc.edu/ 
 
Carlos Sibrian 
 
Department of Plant Biology and Forest Genetics 
               Swedish University of Agricultural Sciences, Uppsala 
 
 
 2 
EX0421 Självständigt arbete i biologi E, 30 hp 
Masterarbete, avancerat E 
 
ISSN 1651-5196 Nr 105 
2009 
 
Kristalliserings försök med TGG5 och mutant studier av TGG4 
myrosinase från backtrav (Arabidopsis thaliana) 
 
Crystallization attempt of TGG5 and mutant studies of TGG4 
myrosinase from thale cress (Arabidopsis thaliana) 
 
 
Carlos Sibrian 
Masterprogrammet i biologi 
 
 
Supervisors:  Prof. Johan Meijer, Ass. profs. Jerry Ståhlberg and Bejai Sarosh 
Examiner: Docent Folke Sitbon 
 
 
Institutionen för växtbiologi och skogsgenetik 
Uppsala Biocenter, SLU 
Box 7080 
75007 Uppsala 
 
SLU, Sveriges lantbruksuniversitet, Uppsala 
 
Institutionen for biologisk grundutbildning 
EBC, Norbyv. 14/ BMC Husarg. 3, Uppsala Universitet 
Norbyv 14/ Box 592, 752 36, 751 24 Uppsla 
 
 
 
 
 
 
 
 3 
Abstract 
 
Myrosinase is a glucosidase normally found in plants of the order Capparales and that is involved in 
the breakdown of glucosinolates releasing toxic breakdown products. Together myrosinase and 
glucosinolates form a plant defence system that deters pests and herbivores by a barrage of toxic 
breakdown products. Many of the crops containing the myrosinase-glucosinolate system are valuable 
vegetable- or oil-crops making studies on myrosinase very important. 
TGG5 and TGG4 are myrosinases belonging to Arabidopsis thaliana. The advantages with using 
myrosinase from a model organism is the extensive knowledge of the organism and the many tools 
and methods developed. Crystallization attempt were performed with recombinant TGG5 (containing a 
his-tag) where the myrosinase was expressed in Pichia pastoris and purified using immobilized metal-
ion affinity chromatography (IMAC) and either cation-exchange chromatography or gel filtration 
chromatography. No crystals were observed but it seemed like the LiSO4 conferred stability to the 
myrosinase enzyme maybe due to interaction with the sulphate binding site of the enzymes usually 
used for binding the sulphate containing substrate. TGG4 is another myrosinase isozyme found in A. 
thaliana and is very similar to TGG5 sharing 97% sequence identity. TGG4 mutants were designed 
using the structure of a crystallised myrosinase from Sinapsis alba as reference. Mutants were 
modified with respect to active site and residues predicted to be involved in substrate binding and co-
factor (ascorbate) binding. Some of the findings were the reduced catalytic activity encountered when 
mutating the glutamine residue (replaced by an glutamate residue in O-β-glucosidases) and that 
converting the glutamine back to glutamate did not confer any additional catalytic activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
TABLE OF CONTENTS 
 
1. INTRODUCTION………………………………………………………………6 
 
1.1.      The Myrosinase-glucosinolate systems in plants……………………………………….6   
1.2. Glucosinolates…………………………………………………………………………..6 
1.3. Myrosinases……………………………………………………………………………..7 
1.4. Three dimensional (3D) structure of myrosinases………………………………………8 
1.5. Myrosinases in Arabidopsis thaliana……………………………………………………9 
1.6. Aim of the work…………………………………………………………………………9 
 
2. METHODS……………………………………………………………………10 
 
2.1 Expression of recombinant protein using the Pichia pastoris expression kit……….…10 
2.2 Inoculation and biomass accumulation of P. pastoris…………………………….…...10 
2.3 Inducing recombinant TGG5 expression in P. pastoris……………………..…………10 
2.4 Harvesting of cells……………………………………………………………………...11 
2.5 Crude cell extract preparation………………………………………………………….11 
2.6 Immobilized metal-ion affinity chromatography (IMAC) for purification of poly-
histidine tagged recombinant proteins…………………………………………………11 
2.7 Cationic exchange chromatography……………………………………………………12 
2.8 Gel filtration chromatography………………………………………………………….12 
2.9 SDS-polyacrylamide gel electrophoresis of proteins…………………………………..13 
2.10 Western blot analysis..………………………………………………………………….13 
2.11 MALDI-TOF Mass spectrometry ...…………..………………………………………..14 
2.12 Peptide mass fingerprinting…………………………………………………………….14 
2.13 De-salting………………………………………………………………………………14 
2.14 Concentration of Protein ………..……………………………………………………..14 
2.15 Enzymatic de-glycosylation……………………………………………………………15 
2.16 Determination of protein concentration using A280……………………………………15 
2.17 Determination of protein concentration using the Bradford assay………………..……16 
2.18 Enzyme assay of alcohol oxidase ……………………………………………………...16 
2.19 Enzyme assay of myrosinase activity using sinigrin as substrate……………….…..…17 
2.20 Enzyme assay of myrosinase activity with addition of ascorbic acid………………….17 
2.21 Enzyme assay of O-β-glucosidase activity of myrosinase……….…………………….18 
2.22 Hanging drop crystallization…………………………………………………………...18 
2.23 Optimum solubility screen (OSS)……………………………………………………...18 
2.24 JCSGplus screen………………………………………………………………………..19 
 
 
3. RESULTS……………………………………………………………………….19 
 
3.1 First TGG5 crystallization attempt…………………………………………………..19 
3.1.1. Expression of recombinant TGG5, crude extract preparation and first step in 
purification……………………………………………………………………...19 
3.1.2. Second purification step ...……………………………………………………...20 
 
            3.2       Second TGG5 crystallization attempt…………………………...…………………..21 
3.2.1. Crude extract preparation and first step in purification…………………………….21 
 5 
3.2.2. First gel filtration……...……………………………………………………………23 
3.2.3. Second gel filtration………...……………………………………………………...24 
3.2.4. Hanging drop vapour diffusion crystallization……………………………………..26 
3.2.5. Third gel filtration…...…………………………..…………………………………26 
3.2.6. Optimum solubility screen (OSS)………………………………………………….27 
3.2.7. JCSGplus screen……………………………………………………………………28 
 
           3.3        TGG5 molecular mass estimation using mass spectrometry…………...………….29 
 
3.4 Determination of the identity of the contaminants ………………………………...31 
3.4.1. Western blot analysis..……………………………………………………………..31 
3.4.2. Enzyme assay of alcohol oxidase…….…………………………………………….31 
3.4.3. MALDI-TOF………………………………………………………………………32 
 
3.5 Myrosinase mutant activity studies – first attempt…………………………………32 
                  3.5.1.    Myrosinase activity assay using sinigrin as substrate……………………………..33 
                  3.5.2.    O-β-glucosidase activity using pNPG as substrate..………………………………33 
 
3.6 Mutant myrosinase activity studies – second attempt……………………………...34 
3.6.1. Myrosinase activity using sinigrin as substrate………….………………………..35 
3.6.2. O-β-glucosidase  activity using pNPG as substrate………...……………………..36 
3.6.3. Myrosinase activity using sinigrin as substrate with addition of ascorbate……….36 
 
4. DISCUSSION…………………………………………………………………..37 
 
4.1. TGG5 Crystallization attempt……………………………………………………….37 
4.2. TGG5 molecular mass estimation…………...……………………………………….39 
4.3. Determination of the identity of the contaminant………….……………………….39 
4.4. Mutant myrosinase activity studies………………………………………………….40 
4.5. Ascorbate vs sinigrin………………………………………………………………….42 
 
5. CONCLUSIONS...……………………………………………………………..42 
6. REFERENCES…………………………………………………………………43 
 
APPENDIX 1       BLAST results of contaminant protein partial sequences……………...47 
          APPENDIX 2       TGG4 mutations based on the 1E71 crystal structure from Sinapsis             
                                                Alba…………………………………………………………………….48 
          APPENDIX 3       Amino acid sequence comparison of plant glycosidases……………….49 
        APPENDIX 4    Graphs displaying enzyme activity towards sinigrin with different                              
                                     concentrations of ascorbate..………………………………………….50 
 
 
 
 
 
 
 
 
 6 
1. Introduction 
 
1.1. The Myrosinase-glucosinolate system in plants 
 
The myrosinase-glucosinolate system is a plant defence system found among plants of the order 
Capparales and in particular in the Brassicaceae family. Glucosinolates and myrosinases are spatially 
separated but come in contact with each other during tissue damage usually caused by herbivores. The 
myrosinase then hydrolyses the glucosinolates giving rise to different toxic breakdown products 
(Windsor et al. 2005). These toxic breakdown products are deterring against herbivores such as birds, 
mammals, molluscs and insects (Mithen 2001a) and might also be effective against microorganism 
(Aires et al. 2008). Glucosinolates have been known for over hundred years but the molecular tools 
and the use of the model plant Arabidopsis thaliana has allowed advances which would have been 
hard to achieve using only biochemical methods (Mithen 2001b). 
 
1.2. Glucosinolates 
 
Glucosinolates are secondary metabolites related to cyanogenic glucosides and are primarily found in 
the order Capparales. Glucosinolates are characteristics of plants belonging to Brassicaceae such as 
Brassica napus, a major oil crop and has therefore attracted much attention (Rask et al. 2000). The 
core structure in glucosinolates consists of a β-thio-glucose moiety, a sulfonated oxime and a side 
chain of variable structure (Mithen 2001a). This side-chain is usually derived from amino acids 
(methionine, phenylalanine, valine, thryptophan, tyrosine, isoleucine, leucine or alanine) and chain 
extended homologous of phenylalanine and methionine (Kliebenstein et al. 2005). This side-chain is 
responsible for the classification into aliphatic, aromatic and indole glucosinolates depending on 
whether they are derived from aliphatic amino acids (isoleucine, leucine, valine, alanine and 
methionine), aromatic amino acids (tyrosine, phenylalanine) or indole (tryptophan) (Wittstock & 
Halkier 2002). 
 
A. thaliana contains more than thirty different glucosinolates where the majority is derived from 
tryptophan and chain extended homologous of methionine although the type of glucosinolate and the 
amount might differ among ecotypes (Kliebenstein et al. 2005). Glucosinolates are not biologically 
active until hydrolysed by myrosinase enzymes. The glucosinolate then forms a thiohydroximate-O-
sulfate and a D-glucose. The thiohydroximate-O-sulfate can be converted into different toxic products 
either spontaneously (isothiocyanates) or with the help of other proteins (nitriles). Available metal ions 
and local pH are other factors important in the formation of different toxic compounds (fig. 1)(Bones 
& Rossiter 2006). 
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Fig. 1. Glucosinolates are hydrolysed by myrosinase producing a D-glucose and thiohydroximate-O-sulfate molecule. The 
thiohydroximate-O-sulfate can react further to produce different kind of toxic products.  
 
1.3. Myrosinases 
 
Myrosinase is a glucosidase and hydrolyses the thio-ether glycoside bond between carbohydrates and 
sulphur linked aglycone side chains present in glucosinolates. Glucosidases are grouped into families 
based on substrate specificity and occasionally on molecular mechanism. Myrosinases are grouped 
into the glycosyl hydrolase family 1, a family consisting mainly of O-β-glucosidases (Expasy).  
 
The O-β-glucosidase members of the glycosyl hydrolase family 1 hydrolyse the O-ether glycosidic 
bond using two glutamate residues acting as catalytic proton donor/acid and catalytic nucleophile/base. 
Depending on the spatial position of the catalytic residues the hydrolysis occurs either with retention 
or inversion of the anomeric configuration (the attached group at the C-1 atom either changes position 
to the α- or β-form or retains it’s position) (Henrissat 1997; Davies & Henrissat 1995). The β-
glucosidases of glycosyl hydrolase family 1 uses retention (Expasy). 
 
Myrosinases are the only known S-glucosidases and are capable of hydrolysing glycosidic bonds 
between glucosinolates and sulphur. Myrosinases differ from β-glucosidases in that the catalytic 
glutamate residue has been replaced with a glutamine residue; this means that myrosinases are missing 
a catalytic acid residue. Hydrolysis is still possible due to the use of water molecules positioned by the 
glutamine residue and the excellent leaving group abilities of the aglycon (Borderioux et al. 2005). 
This also means that myrosinases will not be able to cleave glucosinolates with poor aglycon leaving 
groups. The role of the catalytic acid/base (second glutamate) is believed to have been replaced by 
ascorbate that enters the empty active site left by the aglycon and activates the water molecule  
(Husebye et al. 2005).  
 
High concentrations of ascorbate inhibit the myrosinase activity. This might be because of the fact that 
the aglycone of the glucosinolate and the ascorbate occupy almost the same site. Accordingly a high 
concentration of ascorbate makes it difficult for the glucosinolate to bind (Burmeister et al. 2000). 
Myrosinases are usually restricted to a special type of cells known as idioblasts or myrosin cells. These 
cells occur as scattered cells in seed, seedlings roots, stem, petal and leaf (Rask et al. 2000). 
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1.4. Three dimensional (3D) structure of myrosinases 
 
The first myrosinase structure to ever be crystalized belonged to white mustard (Sinapsis alba) and it 
continuous to be the major reference in myrosinase structure analysis (fig. 2). Myrosinase is a dimer in 
solution and is stabilized by a Zn2+ ion. The myrosinase also has a (αβ)8 barrel fold a common for  
members of family 1 glycosidases. The surface of the protein is heavily glycosylated and the protein 
increases its stability in several ways. These include three disulphide bridges, numerous salt bridges 
and hydrogen bonds between the main chain atoms and charged residues (Burmeister et al. 1997).  
 
 
Fig. 2. The only available plant myrosinase structure is from Sinapsis alba (white mustard) and was elucidated  by 
Burmeister et al (1997). Being the only available structure it serves as a major reference for work with myrosinases. The 
enzyme is a dimer with a stabilizing Zn2+ ion. The structure is annotated as 1MYR in the RCSB protein data bank. 
 
The molecular masses of native myrosinases are estimated to be 135-150 kDa with the subunits often 
being around 59 kDa. Plant myrosinases are higly glycosylated proteins and it is estimated that the 
carbohydrate side chains make up between 10-20 % of the molecular mass of the myrosinase subunit. 
The carbohydrates are usually mannose, fucose and N-acetylglucosamine (Rask et al. 2000). Both the 
heavy glycosylation on the surface, the dimer formation and the many stabilizing bonds (disulphide 
bridges, hydrogen bonds etc) might be an adaptation to the dehydrated conditions occurring in mature 
seeds. But these conditions can differ between different isoforms expressed in other parts of the plant 
(Burmeister et al. 1997).  
  
Another available myrosinase structure belongs to the cabbage aphid (Brevicryne brassicae) and has 
been found to have many similarities as well as differences. The most striking difference is that a 
glutamine has been replaced with glutamate, the acid-base residue most commonly found in O-
glycosidases. This indicates that the aphid myrosinase has a different enzymatic reaction mechanism 
compared with plant myrosinases (Husebye et al. 2005). 
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1.5. Myrosinases in Arabidopsis thaliana 
 
Arabidopsis has in contrast to other Brassicaceae species only one gene family coding for the six forms 
of myrosinases (TGG1-TGG6) found in this plant. TGG1 and TGG2 are both functional enzymes 
found in above ground tissues (Barth & Jander 2006). TGG3 is believed to be a pseudo gene and is 
found in stamens and petals ( Zhang et al. 2002). TGG4 and TGG5 are only found in root tissue 
(according to transcript analysis) while TGG6 is found in the flowers particularly in the stamen ( Barth 
& Jander 2006). In my project I expressed the TGG5 recombinant enzyme and different mutants of the 
TGG4 enzyme using the Pichia pastoris expression system from Invitrogen. The unprocessed TGG5 
peptide has an estimated Mw of 57.469 kDa, contains 511 amino acids and a pI of 8.2. The 
unprocessed TGG4 peptide chain has a Mw of 57.542 kDa, contains 511 amino acids and has a pI of 
8.2.  
 
1.6. Aim of the work 
 
The aim of this project was to increase the knowledge about myrosinase structure-function 
relationships. I made an attempt to crystallize the TGG5 myrosinase found in A. thaliana and to 
estimate its molecular mass using mass spectrometry. I also tried to perform mutant activity studies 
using TGG4 variants mutated at the active site and binding sites for ascorbate and the substrate 
(appendix 2). The general idea was that because TGG4 and TGG5 are almost identical any findings in 
either the crystallization or the mutant studies could be superimposed on the other (fig. 3). A sidetrack 
was made in order to identify a contaminant that due to its ubiquitous nature and nickel affinity created 
problems. 
 
 
Fig. 3. TGG4 and TGG5 are two very similar myrosinase isozymes both found in root tissue and containing 511 amino 
acids. When aligned using Clustal-W they show 97 % sequence identity. The yellow shaded letters represent the 
differences between TGG4 and TGG5. 
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2. Methods 
 
2.1. Expression of recombinant protein using the Pichia pastoris expression kit 
 
Pichia pastoris is a methylotropic yeast often used as host for expression of recombinant protein due to 
the fact that it can perform post-translational modifications and express a reasonable amount of 
proteins (Higgins 1995). One of the appeals with this expression system is that it has a strong inducible 
promoter activated in the presence of methanol. This promoter is coupled to the alcohol oxidase 
enzymes that are compartmentalized into the peroxisomes (Ozimek et al. 2005). When grown on 
methanol the peroxisomes may take up to 80 % of the total cell volume and the alcohol oxidase 
enzyme can make up to 30 % of the total protein in the yeast cell (Daly & Hears 2005). P. pastoris has 
two types of alcohol oxidases. AOX1 and AOX2, where AOX1 is responsible for the brunt of alcohol 
oxidase activity. This is the reason why the protein to be expressed is often coupled to the AOX1 
promoter (Higgins & Cregg 1998). Proteins expressed by P. pastoris has the drawback that they are 
heavily glycosylated with N-linked oligosaccharide chains of mannose (8-14 mannose residues per 
side chain) but this is still much less then for the yeast Saccharomyces cerevisiae (50-150 mannose 
residues per side chain) (Nøhr et al. 2003). 
 
 The P. pastoris strain used was developed in a previous project using a GS115 strain and the pPIC3.5 
expression vector containing the AOX1 promoter and has intracellular expression of the recombinant 
protein. 
 
2.2. Inoculation and biomass accumulation of P. pastoris  
 
The culture is often saturated with cells before the recombinant protein is expressed. Glycerol is a 
carbon source, which allows a faster growth and does not repress transcription as strongly as glucose, 
making it easier to induce expression when changing to methanol containing media (Inan & Meagher 
2001). 
 
 One clone from the recombined P. pastoris GS115 strain (developed in a previous project) was 
inoculated in 5 ml BMGY at 28°C with shaking. When a satisfying turbidity was reached, 5 ml was 
transferred to a 500 ml Erlenmeyer flask containing 250 ml BMGY and grown at 28°C with shaking.  
 
2.3. Inducing recombinant TGG5 expression in P. pastoris 
 
To induce expression of the AOX1 promoter coupled protein the BMGY media must be removed and 
changed to a methanol-containing BMMY media. The methanol concentration of the media is set to 
0.5 % because higher concentration might have toxic effects or decrease the growth of the yeast 
(Murray 1989; Guarna et al. 1997). New methanol is added on a daily basis to a concentration of 0.5 % 
to compensate for loss due to evaporation or consumption. Since alcohol oxidase has poor oxygen 
affinity it is important to assure good aeration of the culture (Higgins & Cregg 1998).  
 
When the culture achieved an OD600 of 2-6, the culture was centrifuged at 3,000g for 5 min at room 
temperature using 50 ml Falcon tubes. The supernatant was removed and the pellet  resuspended in 
BMMY until an OD600 of 1 was reached (~ 5 x 10
7 cells/ml). The BMMY medium contains 0.5 % 
methanol that induces expression of TGG5. New methanol is added each day to a final concentration 
of 0.5 %. The culture is grown in a Fernbach flask at 28°C with shaking. The flask is capped with 
cheesecloth and fresh methanol is added using a syringe. 
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2.4. Harvesting of cells 
 
Since the recombinant protein has intracellular expression the yeast cells are collected and the 
supernatant removed. 
 
Cells were harvested by centrifugation at 3,500g for 15 min using either 250 ml or 500 ml plastic 
bottles. The supernatant was poured out, the pellet resuspended in sterile water and then once again 
centrifuged at 3,500g for 15 min. The supernatant was removed and the pellet stored at -20°C until 
used. 
 
2.5. Crude cell extract preparation 
 
The cell pellet was weighed and then resuspended in a volume of start buffer roughly twice the weight 
of the cell pellet. This start buffer also contained several protease inhibitors such as 1 mM PMSF, 1 
mM Benzamidine and 1 ml/100 ml of protease inhibitor cocktail (Roche). The resuspended cells were 
transferred to 2 ml tubes half filled with either glass beads (0.5 mm) or silica beads (0.5 mm). The cells 
in the tubes were disrupted using a bead beater. Shaking the tubes at maximum speed makes the beads 
rupture the tough yeast cells and homogenising the solution. The process is alternated between 45 sec 
with beat beating and 45 sec sample cooling in ice bath incubation and is repeated 5-7 times. The tubes 
were centrifuged at 12,000g for 10 min and the supernatant transferred into 34-SS tubes. The 
supernatant was centrifuged at 15,000g for 20 min at 4°C. This was done in order to remove cell debris 
that forms a pellet at the bottom of the tube. The supernatant was transferred to a new tube and the 
process repeated until no cell debris was visible. The supernatant was finally filtrated through a 0.20 
µm filter and a 100 µl crude extract sample saved for activity assays while the rest was stored at 4°C. 
 
2.6. Immobilized metal-ion affinity chromatography (IMAC) for purification of poly-histidine 
tagged recombinant proteins 
 
IMAC is an affinity chromatography technique and separates proteins based on the reversible binding 
between amino acids and metal ions. Histidine, cysteine and tryptophan are residues with a natural 
affinity to metal ions, but one can also create affinity by attaching histidine residues to a protein (his-
tag). The histidine residues are able to bind to bivalent cations such as Zn2+, Co2+, Ca2+, Cu2+, Fe2+ and 
Ni2+. Matrixes with bivalent cation ligands are used to separate the recombinant protein from native 
proteins that usually do not have metal-affinity. Imidizole is the chemical of choice when reversing the 
binding to the ligand as it also has a metal-ion affinity (Charlton & Zachariou 2007). Purification of 
recombinant protein (6xHis) is performed using pre-packed columns, either Histrap Hp 5 ml column 
(GE healthcare) or Ni-NTA superflow cartridge 1 ml columns (Qiagen). Both columns are pre-packed 
with Ni2+ as ligand and are stripped and recharged after each use. 
 
A pump (Gilson) with a flow rate of 1 ml/min was used. The column was equilibrated with 10 column 
volumes of start buffer (binding buffer) before loading the pre-treated yeast crude extract. The column 
was washed with 10 column volumes of washing buffer. Unspecific proteins were eluted with 5 
column volumes elution buffer A. The flow-through was collected in one 50 ml tube. Proteins with 
affinity to the Ni2+ ligand were eluted with elution buffer B and collected in 1ml fractions. The whole 
procedure was performed either at room temperature or at 4°C.  Fractions were stored at 4°C and later 
analysed for enzymatic activity and protein concentration. The columns were stripped and recharged 
by first washing with 5 column volumes water and then stripping the nickel ions with 10 column 
volumes stripping buffer. The column was washed once more with 10 column volumes water and then 
recharged with  2-2.5 ml 0.1M NiCl solution. The column was washed for a final time with 5 column 
volumes water and stored at 4°C.   
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2.7. Cationic exchange chromatography 
 
Ion exchange chromatography relies on charge interactions between charged groups in the protein and 
the charges in the resin matrix. The charge of the protein is dependent on the pI where a pH under the 
pI will give it a positive charge and a pH over pI will give it a negative charge (Amersham Biosciences 
manual). In a cation exchange chromatography the charged amino acids consist of histidine (pKa 6.5), 
lysine (pKa 10) and arginine (pKa 12) while an anion exchange relies on the charged aspartic (pKa 
4.4) and glutamic acid (pKa 4.4) (VHP high-perfomance ion-exchange columns manual). The start 
buffer is selected according to the isoelectric point with an optimal pH of 1-2 pH units from the 
isoelectric point. The start buffer should also have low ionic strength and to ensure good buffering 
capacity, the pKa should not be more then 0.5 pH units from the pH of the buffer used. The stationary 
matrix is made of anionic charged groups such as –COO-, OPO3
- and SO3
- (Source 30Q and 30S 
instructions), elution is achieved by applying a stepwise increase in ionic strength of the elution buffer. 
 
A 10 cm column packed with Source 30S (GE Healthcare) was used for cation exchange 
chromatography. The matrix consists of polystyrene/divinyl benzene and a S-resin (sulphate 
derivatives) as ion exchanger with the charged group ROCH2CHOHCH2OCH2CHOHCH2SO3
-. The 
net charge of the protein has to be positive to bind to the resin. TGG5 has a pI of 8.2 therefore we use 
20 mM sodium phosphate buffer with pH 6.75 (pKa 7) leaving the TGG5 protein positively charged. 
The ÄKTA-explorer system (GE Healthcare) was used for the cation exchange chromatography, this 
includes pre-equilibration of the column, running the protein sample and eluting the protein sample. 
The column was pre-equilibrated with buffer A and thereafter loaded with the sample and run with a 
flowrate of 1.5 ml/min. The bound protein was eluted with buffer B using a salt gradient going from     
0-1 M (75 ml) and Na+ as the displacer ion. A fraction-collector coupled to the ÄKTA-system was 
used to collect 2.2 ml fractions. UNICORN (GE Healthcare) software was used to detect the data in 
real-time. 
 
2.8. Gel filtration chromatography 
 
Gel filtration chromatography or size-exclusion chromatography is a method that separates proteins 
based on their molecular size. The gel media contain small pores that retains smaller molecules while 
larger molecules will be excluded from pores to varying extents (Bollag 1994). According to this 
scheme, the larger proteins are eluted first while smaller proteins are retarded and eluted later. The 
column matrix must be chosen such that it allows the best separation between the protein of interest 
and the contaminant. The protein of interest should be eluted first but not with the void volume, which 
contains molecules too large to enter any of the pores. The column itself should be long and narrow to 
allow good separation of the proteins (Stanton 2003). Due to the size-exclusion character of this 
chromatography method it is also a good way to change buffers as the proteins move faster through the 
column then the buffer molecules. It is also the most gentle separation method with high recovery. 
 
Superdex 200 prep grade was the matrix used and has an optimal separation range between 10 kDa and 
600 kDa. The column containing the pre-packed matrix was 60 cm long. The column was pre-
equilibrated with 20 mM imidazole buffer (also containing 0.1M NaCl) with 0.5 ml/min flow rate. The 
same buffer and flow rate was used when eluting the protein. The ÄKTA-explorer system was used for 
the gel filtration chromatography. The protein sample was loaded into the injectionvalve of the system 
and was allowed to run for 20-40 min before starting the fraction-collector. Two ml fractions were 
collected for 5 hours or 150 ml. The column was run with 150 ml 20 % etanol before being stored at 
4°C.  The fractions were marked and stored at 4°C. 
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2.9. SDS-Polyacrylamide gel electrophoresis of proteins 
 
SDS-PAGE is a widely used technique to separate proteins depending on their molecular mass. 
Proteins are mixed with the anionic detergent sodium dodecylsulfate (SDS) making the proteins form 
negatively charged complexes and thus allowing them to run through the gel. SDS binds 
approximately with a ratio of 1.4 gram SDS for each gram of protein (Smith 1994). The reducing agent 
(dithiothreitol or β-mercaptoethanol) was added to the samples to break inter- and intra-molecular 
disulphide bridges and thus making the protein lose its quaternary structure and dissociate into its 
subunits. This also allows the protein to form more uniform complexes with SDS (Blancher & Jones 
2008). 
 
Protein sample (2 µl) was mixed with 5.5 µl loading dye (200 µl loading buffer + 10 µl 1 M DDT ). 
The mixture was heated for 5 min at 95°C, centrifuged briefly and then loaded on a 4-12 % “Ready-to-
use” gel (C.B.S Scientific), which was mounted on a vertical running chamber. The running chamber 
was filled with running buffer (C.B.S Scientific). A voltage of 150 mV was run through the gel for 1 
hour. The gel was then fixed in fixing solution for 5 min and incubated in Coomassie blue solution for 
at least 4 hours. The gel was destained with de-staining solution. A standard from Fermentas was used. 
When using the phastsystem (GE Healthcare), a somewhat different protocol was used. Protein sample 
(4 µl) was mixed with 1 µl loading buffer (5X buffer containing β-mercaptoethanol). The mixture was 
heated at 106°C for 5 min, centrifuged briefly and then loaded on a phastgel (8-25 %) and separated 
using the phastsystem workstation. The gel was stained with Coomassie blue solution, heated briefly in 
microwave for 10 seconds and incubated for 20-40 min. The gel was de-stained with de-staining 
solution (not the same as the one used for C.B.S Scientific gels). A LMW marker was prepared by 
mixing 2 µl LMW with 6 µl water, 2 µl loading buffer and then heated briefly at 106°C. 
 
2.10. Western blot analysis 
 
Western blotting involves the separation of protein on acrylamide gel and then transfer of the proteins 
from the gel to a membrane. The membrane is more stable and easier to work with then the acrylamide 
gel and also allows further analytical procedures (Walker 1986). In this case a primary anti-his 
antibody was used to bind recombinant proteins with his-tags, while a HRP secondary secondary 
antibody was used for detection. 
 
One piece of PVDF membrane was cut slightly larger than the gel and soaked in 100% methanol for 
10 min and then soaked in blotting buffer. The protein of interest was submitted to SDS-PAGE, the 
acquired gel was immersed in blotting buffer where after the PVDF membrane was placed onto the gel 
and made sure that no air bubbles were present. Whatman filter paper was cut into four rectangular 
pieces slightly larger then the gel. Two Whatman filter papers were dipped into blotting buffer until 
wet and the placed on top of the PVDF membrane. The gel, PVDF membrane and paper was turned to 
the other side where two more wet Whatman filter were placed on top. This paper-membrane-gel-
paper sandwich was placed in a blot cell with the PVDF membrane side towards the positive electrode 
and submitted to electroblotting, which transfers the proteins from the gel to the membrane. 
The blot (PVDF membrane) was then incubated in blocking buffer on a rocking table overnight at 4°C. 
The blot was briefly soaked in PBST to remove excess blocking buffer. The PBST was poured of and 
the blot incubated in 1.5 ml primary antibody diluted in PBST (1:3000). The blot was incubated for 1 
hour at room temperature. The primary antibody was removed and the blot washed thrice in PBST (the 
blot was submerged in PBST for 10 min). The blot was then incubated in HRP conjugated secondary 
antibody (diluted in PBST to 1:1000) for 1 hour at room temperature. The blot was washed thrice in 
PBST (10 min). Excess PBST was poured off and the blot incubated in a small volume of ECL reagent 
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(50:50 mix of the two solutions) for 5 min. Excess ECL reagent was removed and the blot placed in a 
thin plastic film and the protein detected using chemiluminescence.  
 
2.11. MALDI-TOF Mass spectrometry 
 
The principle of mass spectrometry is that the path of charged particles (ions) will vary on their way 
through an electric and magnetic field depending on their charge-to-mass ratio. A mass spectrometer 
consist of three modules an ion source, which ionises the molecules, an analyser which sort the ions by 
their masses and a detector which measures the charge induced or the current produced when the 
charged particle hits a surface (Roepstorff 2005). During this project the MALDI-TOF variant of mass 
spectrometry was used. MALDI stands for matrix-assisted laser desorption ionisation and requires that 
the particle of interest was mixed with an excess of matrix molecules. The matrix usually consists of 
organic aromatic acids that after irradiation by a laser are sublimated allowing the non-volatile protein 
molecules to transfer into gas-phase as singly charged particles (Yates 2001). TOF or time-of-flight is 
the analyser used and uses an electric field to accelerate the charged particles and measure the time 
they take to reach the detector (Van Den Boom & Ehrich 2007). Åke Engström at Uppsala proteomics 
platform, BMC performed the MALDI-TOF procedure and I received the results in the form of mass 
spectra. 
 
2.12. Peptide mass fingerprinting 
 
In a peptide mass fingerprinting the protein is treated with proteolytic enzymes such as trypsin or 
pepsin and the resulting peptide fragments are analysed with mass spectrometry. Trypsin is an 
especially useful protease as it produces peptides in the 0.8– 4 kDa size range (Yates 2001). 
The mass spectrum acquired can provide a fingerprint of the enzyme and the peptide mass values can 
be compared to other mass values from databases (Cottrell & Sutton 1996). Åke Engström performed 
peptide mass fingerprinting on the 38 kDa contaminant using MALDI-TOF and correlated the data to 
the MASCOT database. 
 
Åke Engström also performed de novo sequencing on several peptide fragments by using the mass 
spectrometer and knowing the approximate masses of each amino acid (Gevaert & Vandekerckhove 
2005). 
 
2.13. De-salting 
 
The protein was de-salted using a PD-10 desalting column (GE Healthcare) containing a Sephadex G-
25 medium matrix (GE Healthcare) capable of separating high molecular weight substances (Mw > 
5000 Da) from low molecular weight substances (Mw < 1000 Da). The column was equilibrated with 
15 ml of the desired buffer and then 3 ml of the sample was applied and allowed to run through. Four 
ml of the desired buffer was added and the flow-through collected. Because low molecular mass ions 
run more slowly through the matrix, only the protein will be collected and suspended in the buffer of 
choice. The protein sample was stored at 4°C. The column was washed with 15 ml 0.02 % Na-Azide 
and then stored with 2-5 ml 0.02 % Na-Azide. 
 
2.14. Concentration of protein 
 
The protein was concentrated by membrane ultrafiltration. This procedure usually uses a single tube 
containing two compartments and a semi-permeable membrane with a molecular cut-off between the 
compartments. The solvent and low-molecular molecules are forced through the membrane by 
centrifugal forces while the protein remains in the upper compartment and thus gets more 
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concentrated. By adding a different solvent and continue the centrifugation until all ions from the 
previous solvent has passed the membrane, it is possible to change the buffer if needed. Vivaspin-20 
(GE Healthcare) columns were used for concentration of the protein except when the volume was 
under 1 ml when a vivaspin-500 (GE Healthcare) column was used. The columns were washed with 
de-ionized water before use. 
 
2.15. Enzymatic de-glycosylation 
 
When expressed in P. pastoris the protein gets glycosylated with N-linked oligosacharide chains of 
mannose residues. The N-linked glycans are attached to asparagines through an amide bond (Harvey 
2003). Treatment with α-mannosidase can cleave alpha-(1,2), (1,3) and (1,6) terminal residues and at a 
slower rate the 1,4 – linked terminal mannose residue (α-mannosidase product information, SIGMA). 
Pretreating with α-mannosidase might also make it easier for Endoglycosidase-H to cleave between the 
two innermost GlcAc residues of the N-linked glycan leaving one GlcAc residue attached to the 
asparagines (EndoH product information, SIGMA). Removing glycosidase residues might make it 
easier to crystallize the protein and to get Mass spectra using MALDI-TOF but there is also the 
possibility that the protein becomes unstable and unfolds. 
 
The protein was diluted in 50 mM NaAcetate pH.5, and concentrated to a concentration of choice. 
ZnAcetate is added to a final concentration of 20 mM and to this 50 µg α-mannosidase was added. 
This mixture was sterile filtered through a 0.2 µm filter and then incubated at room temperature. 
Aliquots were taken before and after addition of α-mannosidase and stored at 4°C.  
 The TGG5 protein was left to crystallize together with 1:100 de-glycosylation protein either with α-
mannosidase or with both α-mannosidase and endo-H. In the mixture containing α-mannosidase the 
final concentrations were 1 mM ZnAcetate, 2 mg/ml of TGG5 and 0.02 mg/ml of α-mannosidase. A 
similar mixture was prepared with the only difference that it contained 0.02 mg/ml endo-H. The 
mixture (2.4 µl) was set up together with 0.8 µl crystalisation buffer giving 3.2 µl drops. These drops 
were incubated at 20°C. The drops contained variable buffers but the pH was usually between pH 4.2 
and 5. 
 
2.16. Determination of protein concentration using A280 
 
Protein concentration can be estimated using the fact that aromatic amino acids, tryptophan and 
tyrosine and also disulfide bonded cysteine residues exhibit UV-light absorption at wavelengths of 280 
nm (Simonian & Smith 2006). Out of these residues, tryptophan has the highest absorbance as it 
absorbs UV-light almost five times greater then tyrosine and 50 times more then disulfide bonded 
cysteine residues. This means that the protein measured must have aromatic amino acids especially 
tryptophan, because every protein has a different composition of these three UV-absorbing residues a 
coefficient must be used to be able to get comparable values. This coefficient is known as the molar 
absorption coefficient (ε) and is the sum of the three major UV-absorbing amino acid residues at 
280nm (Simonian 2002). 
 
ε = ((n*tryptophan)*5500)+((n*tyrosine)+1490)+((n*Cysteine)*125) 
  
n is the number of each residue while 5500, 1490 and 125 are the values for amino acid molar 
absorptivities at 280nm for the corresponding amino acids. 
 
The absorbance of the protein was measured using a spectrophotometer (SHIMADZU UV 1800) using 
a spectrum between 340-240nm. The spectrophotometer was blanked at the spectrum of choice, a 1 cm 
width quartz cuvette was used and the volume was always 1 ml. The absorbance of the sample was 
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measured and peaks at 280nm were annotated. When large volumes can not be used for measuring 
protein concentration, a nanodrop spectrophotometer was used instead. The procedure is similar but 
instead of a spectrum only the 280nm wavelength was used and only 2 µl of the sample was needed to 
measure the protein concentration. The following equation can be used to calculate a protein 
concentration using the molar absorption coefficient, absorbance and molecular weight of the protein: 
 
Concentration (mg/ml) = (A280*molecular weight) / (ε280 * 1 cm) 
 
2.17. Determination of protein concentration using the Bradford assay 
 
The Bradford assay is dye-binding technique and is a colorimetric assay as the colour of the test 
sample changes with the protein concentration. The dye Coomassie brilliant blue G-250 shifts its 
absorbance maximum from 465nm to 595nm upon binding to basic amino acids (arginine) and 
aromatic amino acids in acidic solution. Binding to protein changes the colour of the dye from reddish-
brown to blue (the more protein the darker the blue colour) (Kruger 1996). 
 
A microtiter plate protocol was used where the sample was prepared in a 96 well microplate and 
analysed at 595nm with a microplate reader (FLOUstar OMEGA). Bovine serum albumin (Fermentas) 
was used to set up a standard curve with known protein concentration to which the absorbance of the 
sample can be compared. The concentration range of the standards goes from 0.05 mg/ml through 01, 
0.2, 0.3, 0.5, 0.8 and 1 mg/ml. 
 
2.18. Enzyme assay of alcohol oxidase 
 
P. pastoris has two genes coding for alcohol oxidase, AOX1 and AOX2. Out of these two, the AOX1 
gene codes for the protein responsible for almost all alcohol oxidase activity (Gregg et al. 1989). 
AOX1 functions as a octamer of 8 identical subunits each of which binds a FAD cofactor (Ozimek et 
al. 2005). Each subunit has 663 amino acids (www.uniprot.org) and a molecular mass of ~ 72 kDa. 
When assembled in the functional octamer, the molecular mass is ~ 675 kDa (Ellis et al. 1985). When 
oxidizing methanol, Alcohol oxidase generates formaldehyde and hydrogen peroxide. Due to the 
toxicity of hydrogen peroxide, the process is carried out in peroxisomes to which the enzyme is 
confined (Gregg et al. 1989). The amount of H2O2 can be used as an indication of alcohol oxidase 
activity by the use of peroxidase enzyme and ABTS (2,2’-Azino-bis(3-ethylbenzthiazoline-6-sulfonic 
acid). The ABTS molecule functions as donor giving two water molecules and oxidized ABTS now a 
green soluble end-product. 
 
 
 
ABTS (280 µl, 2 mM) was mixed with 1 µl peroxidase (250 unit/ml) and incubated at 25°C under 
shaking (Eppendorf thermomixer 300 rpm) for 5 minutes. Sample (2-10 µl) and 1 µl hydrogen 
peroxide (0.003%) was added to the mixture and again incubated at 25°C for 5 min. After adding 10 µl 
methanol (1%) incubation at 25°C shaking continued for 10 minutes. Absorbance was read at 405nm 
using a microplate reader (FLOUstar OMEGA). A negative control with 10 µl 100 mM potassium 
phosphate buffer pH 7.5 instead of protein sample was prepared. Crude extract of proteins from P. 
pastoris was used as positive control as it contains a large amount of AOX1. 
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2.19. Enzyme assay of myrosinase activity using sinigrin as substrate 
 
Sinigrin is a glucosinolate and when hydrolysed by myrosinases the sulphur bond is cleaved giving 
secondary metabolites and glucose. The secondary metabolites vary depending on the glucosinolate 
type and environment and are also unstable, all bad characteristics when doing assays to determine 
enzyme activity (Kleinwächter & Selmar 2004). The enzyme activity assay was instead based on 
glucose and a GOD-POD method. The released glucose is oxidized by glucose oxidase (GOD) into 
gluconic acid and hydrogen peroxide. Hydrogen peroxide reacts under catalysis of peroxidase (POD) 
with 4-aminophenazone and phenol to form a red/violet quinineimine dye (Glucose GOD/PAP 
manual, RANDOX). GOD, POD, 4-aminophenazone and phenol are all included in the glucose 
reagent from RANDOX. 
 
 
 
The protein sample was mixed with 50 mM Na-citrate pH 4.5 to a final volume of 25 µl and incubated 
at 37°C for 5 min. The sample was then mixed with 62 µl sinigrin (12.5 mM) and pre-heated to 37°C. 
The mixture was vortexed briefly and incubated at 37°C for 30 min. The reaction was stopped by 
heating at 95°C for 5 min and allowed to cool. After cooling, 250 µl Glucose reagent (Randox) was 
added to each sample and incubated at 37°C for 15 min. A 200 µl aliquot from each sample was 
transferred to a 96 well plate and analysed at 550nm with a microplate reader (FLOUstar OMEGA). A 
standard curve was made using glucose from a glucose test kit (Randox) to calculate the amount of 
released glucose from the samples. Myrosinase activity can be calculated using the following formula: 
 
Total activity in X units (mmol glucose/min) = average of A550*F*dilution factor/30 min 
Specific activity in Y mmol glucose/min mg = total activity / total protein 
F = gradient from standard curve. 
 
2.20. Enzyme assay of myrosinase activity with addition of ascorbic acid 
 
Ascorbic acid is a co-factor of myrosinase and functions as a nucleophile when involved in the 
hydrolysis reaction (Kleinwächter & Selmar 2004). Ascorbate has both a stimulating and inhibiting 
activity as high concentrations of ascorbic acid can inhibit the myrosinase (Burmeister et al. 2000). 
Ascorbate can have some negative effects on GOD-POD method assay as it reacts with hydrogen 
peroxide and inhibits the formation of quinineimine dye (Kleinwächter & Selmar 2004). Even if the 
values may not be absolute in the presence of ascorbate it can still give a good indication of differences 
between different myrosinases and mutants of myrosinases, as long as the ascorbic acid concentration 
is not too high. 
 
The protein sample was mixed with 50 mM Na-citrate pH 4.5 and incubated at 37°C for 5 min. The 
sample was mixed with ascorbic acid (pre-heated to 37°C) to a final volume of 25 µl. Sinigrin (62 µl, 
12.5 mM pre-heated to 37°C) was added. The samples were mixed and incubated at 37°C for 30 min.  
The reaction was stopped by heating at 95°C for 5 min and allowed to cool. After cooling, 250 µl 
Glucose reagent (Randox) was added to each sample and incubated at 37°C for 15min. A 200 µl 
aliquot from each sample was transferred to a 96 well plate and analysed at 550 nm with a microplate 
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reader (FLOUstar OMEGA). Glucose standards from Randox were used to make a standard curve 
estimating the glucose released when myrosinase cleaves sinigrin. Ascorbic acid was freshly prepared 
before each assay and the concentration used ranged from 0.115 to 2.64 mM. 
 
Total activity in X units (mmol glucose/min) = average of A550*F*dilution factor/30 min 
Specific activity in Y mmol glucose/min mg = total activity / total protein 
F = gradient from standard curve. 
 
2.21. Enzyme assay of O-β-glucosidase activity of myrosinase 
 
The protein sample was mixed with 50 mM Na-citrate, pH 4.5, to a final volume of 25 µl. To this 
mixture 25 µl, 5 mM p-nitrophenyl β-D-glucopyranoside (pNPG) was added and then incubated in a 
Eppendorf thermomixer (37°C, 350 rpm) for 30 min. The reaction was stopped by addition of 25 µl 
sodium carbonate and the samples transferred to a 96 well plate. The absorbance was analysed at 405 
nm using a microplate reader (FLOUstar OMEGA). Free 4-nitrophenol was prepared and used to 
construct a standard curve to allow quantification. 
 
 
 
2.22. Hanging drop crystalization 
 
A hanging drop crystallization attempt was set up around crystallization values used earlier by Eva-
Lena Andersson, which gave some protein crystal growth. The crystallization conditions used by Eva-
Lena were 14-28% PEG1000, 0.2 M LiSO4, 0.1 M NaPO4/citrate buffer, pH 4.2. But I was adding de-
glycosylation enzymes in some of the drops to remove mannosidase side-chains and could therefore 
not have phosphate in the buffer as it falls out in the presence of zinc. Therefore I substituted the 
NaPO4 for sodium citrate buffer pH 4.2 and pH 5.0. Since there was no PEG1000 available I had to 
use PEG1500 instead. TGG5 concentrated to 2 mg/ml was used to set up two plates with 18 drops in 
each plate. The drops consisted of 2.4 µl protein+0.8 µl reservoir buffer. The reservoir contained 1 ml 
buffer. Six drops also contained 0.02 mg/ml α-mannosidase (1:100 of TGG5) and another six drops 
contained 0.02 mg/ml α-mannosidase and endoH (1:100). The plate was stored at 20°C. 
 
2.23. Optimum solubility screen (OSS) 
 
The OSS screen was used to test the protein compatibility at different variable conditions, in this case 
pH. Different 1 M buffers with pH ranging from 3 – 10 were used to test the proteins tendency to 
aggregate at different pH values. The reason 1 M buffers were used was to minimize any effect that the 
proteins original solvent may have on the screen. The difference between 20 mM imidazole buffer has 
less effect on 1 M buffer then on the recommended 0.1 M buffer. Hanging drop vapour diffusion was 
used to set up 23 drops. TGG5 protein  concentrated to 2 mg/ml was used to set up drops consisting of 
0.8 µl protein+0.8 µl reservoir buffer while the reservoir contained 50 µl 1 M buffer. 
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2.24. JCSGplus screen 
  
A number of crystallization variables were tested using the JCSGplus screen and sitting drop vapour 
diffusion. The TGG5 protein sample had a concentration of 4 mg/ml and was mixed 1:100 α-
mannosidase and 1:100 endo-H immediately before setting up the drops. Protein (0.8 µl) was added 
together with 0.8 µl reservoir buffer while 50 µl buffer was added to each reservoir. 
 
3. Results 
 
3.1. First TGG5 crystallization attempt 
 
3.1.1. Expression of recombinant TGG5, crude extract preparation and first step in purification. 
 
A previously prepared strain of P. pastoris was used for intracellular expression of recombinant his-
tagged TGG5 under control of the AOX1 promoter. After cultivation of the cells to high density, 
expression was induced with methanol. Cells were harvested and disrupted for preparation of a crude 
protein extract that was fractionated on a Ni-NTA IMAC column.The fractions were tested for 
myrosinase activity and the protein concentration in the samples was estimated using the Bradford 
assay (Bio-Rad) (Table 1). Fractions B3-B11, the flow through and crude extract were analysed on a 4-
12% polyacrylamide gel and stained with coomassie blue. The B5, B6 and B7 fractions gave two 
bands. One was between 60-70 kDa, which is presumed to be the size of the glycosylated TGG5, while 
the other band was a  ~40 kDa contaminant. These three fractions were used for further purification. 
 
 
Table1. Myrosinase fractions tested for enzyme activity and with estimated protein concentration   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Two 50 ml tubes containing cell pellets prepared in the lab in previous experiments (not prepared by 
me) were used. The protein amount acquired from the culture was still a bit low and I wanted to 
increase the protein amount. The pellet was prepared and the crude extract ran through the Histrap        
5 ml column in the same manners as before. The acquired fractions were then tested for myrosinase 
activity and the protein concentration estimated using the Bradford assay (table 2). Fractions B3-B10 
were run on a gel together with the pooled flow-through. Two bands were observed, the TGG5 lying 
between 60-70 kDa while the contaminant lied between 30-40 kDa (fig. 4). 
 
 
 
 
Elution B                 
(1 ml fractions)  
Myrosinase activity 
(mmol /min) 
Protein concentration 
(mg/ml) 
B3 1.7 0.18 
B4 30.1 0.24 
B5 70.3 0.48 
B6 76 0.9 
B7 39.3 0.62 
B8 23.9 0.43 
B9 10.4 0.25 
B10 5.9 0.2 
B11 2.6 0.13 
Flowthrough 1.1 14.51 
Crude extract 32.4 17.6 
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Table2. Myrosinase fractions tested for enzyme activity and with estimated protein concentration   
Elution B                   
(1 ml fractions) 
Myrosinase activity 
(mmol/min) 
Protein concentration 
(mg/ml) 
 B3 14.6 -0.24 
B4 63.7 0.9 
B5 65.8 2 
B6 67.7 1.5 
B7 69.2 1.1 
B8 62.7 1.26 
B9 44.5 0.66 
B10 27.5 3.8E-2 
 
 
 
 
Fig. 4. Lanes 1 to 8 contain the proteins from fraction B3, B4, B5, B6, B7, B8, B9 and B10 respectively. Lane 9 is the 
flowthrough, lane 10 and 11 are not related to the expeiment while lane 12 contains the marker (Fermentas, pagerulerTM 
unstained protein ladder).  
3.1.2. Second purification step 
 
The fractions that gave bands were pooled together for further purification by ion-exchange 
chromatography. The fractions pooled were B5-B7 from the first purification and B4-B10 from the 
second purification. The protein amount was 9.34 mg in the pooled fractions but a great deal of this 
might actually be due to the contaminant. Cation-exchange chromatography was used for further 
purification and was performed using an ÄKTA-system at the SLU Molecular biology department at 
BMC. A salt gradient from 0 to 1 M was used for separation and the protein was eluted in 2.2 ml 
fractions at a flow rate of 1 ml/min. The software used to analyse the separation of proteins was the 
UNICORN program. The contaminant was eluted together with the flow-through while the TGG5 
protein was eluted by increasing the salt gradient (0-1 M NaCl) (fig. 5). 
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Fig. 5. The contaminant is eluted together with elution buffer A (20 mM sodium phosphate pH 6.75) while TGG5 is eluted 
with an increasing salt gradient. Fractions 6-12 were part of the TGG5 peak and saved for SDS-PAGE analysis.  
 
Fractions 6 to 14 were run on two minigels using the Phastsystem workstation (GE Healthcare). 
Fraction 6, 12, 13 and 14 gave one weak band, fractions 7-9 gave a strong band and fraction 10 to 11 
gave very strong bands. A low molecular weight marker was used and it indicated that the protein had 
a molecular mass between 45 kDa and 66 kDa. Some of the bands seemed to consist of two bands 
situated very close to each other. It is very possible that this is a result of heterogenous glycosylation. 
Such heterogenous glycosylation might be one of the reasons that it is difficult to crystallize the 
protein. The fractions were pooled and estimated to contain 2 mg/ml. The buffer was changed to        
50 mM NaAcetate to allow deglycosylation with α-mannosidase. Treatment with α-mannosidase can 
cleave alpha-(1,2)-, (1,3)- and (1,6)- terminal residues giving more homogenous preparations. The 
pooled fractions were concentrated to 2 ml and to this 50 µg α-mannosidase and 48 µl zinc acetate was 
added. It was left at room temperature for two days, When inspecting the sample it looked like there 
was a little precipitation thus I added 2 ml sodium phosphate assuming that it was the NaAcetate 
buffer that was the cause. But I forgot that zinc falls out in the presence of phosphate and there was a 
lot of precipitation. I tried to remove the precipitate but ended up with only 0.4 mg/ml. There was no 
point in removing the cleaved mannosidase residues with ion-exchange and thus it ended the first 
crystallization attempt. 
 
3.2. Second TGG5 crystalization attempt 
3.2.1. Crude extract preparation and first step in purification 
 
Crude extracts were prepared from tubes stored at -20°C that were made in the lab in previous 
experiments. I was told that there were no particular experiments planned for these cell pellets and 
therefore decided to use them for another attempt at protein crystallization. Six separate crude extract 
preparations were made with cell material from the tubes, the amount of protease inhibitor cocktail 
varied between the different preparations due to shortage. The IMAC step was performed at 4°C (the 
first attempt was performed at room temperature) and two types of pre-packed columns were used, 
either Histrap Hp 5 ml column or Ni-NTA superflow cartridge 1 ml columns. The columns were 
stripped and re-loaded with nickel between each run. From the SDS-PAGE gels made for each 
separation it seemed like a lot of the TGG5 protein did not bind. Therefore the flow-through from all 
separations was pooled and used in three separate IMAC runs to try to bind the remaining TGG5. 
Myrosinase assays were performed on all fractions acquired from each IMAC chromatography step. A 
problem with the standard curve linearity was experienced when trying to estimate the protein 
concentration using the Bradford assay. Instead I pooled all fractions with myrosinase activity (table 3) 
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and used SDS-PAGE protein separation to make a rough estimate on how much protein there was in 
the pooled samples (fig. 6). 
 
Table 3. Eluted fractions with myrosinase activity were pooled together and tested for further myrosinase activity. These 
pooled fractions were to be used for further purification to remove the 30-40 kDa contaminant. The two remaining 
separations from the pooled TGG5 flowthrough were not tested for myrosinase activity. 
TGG5 separate 
IMAC runs 
Pooled elution B 
fractions 
Volume Myrosinase activity (mmol /min) 
TGG5 (I) B4, B5, B6, B7, B8, B9, 
B10, B11 
7 ml 47.3 
TGG5 (II) B4, B5, B6, B7, B8, B9, 
B10 
6.5 ml 27.3 
TGG5 (III) B4, B5, B6, B7, B8, B9, 
B10 
6.5 ml 28 
TGG5 (IV) B4, B5, B6, B7, B8, B9, 
B10, B11 
7.5 ml 37.3 
TGG5 (V) B2, B3, B4, B5 3.5 ml 40.1 
TGG5 (VI) B2, B3, B4, B5 3.5 ml 37.2 
Pooled TGG5 
flowthrough (I) 
B2, B3, B4, B5 3.5 ml 18.7 
Pooled TGG5 
flowthrough (II) 
B5, B6, B7 3 ml  
Pooled TGG5 
flowthrough (III) 
B5, B6, B7, B8 3.5 ml  
 
 
 
Fig. 6.  Lanes 1-7 contained the following pooled fractions; TGG5 (I), TGG5 (II), TGG5 (III), TGG5 (IV), TGG5 (V), 
TGG5 (VI) and pooled TGG5 flow-through (I) respectively. Lane 8 separates a TGG4 protein unrelated to this experiment. 
Lane 9 contained the marker. The two remaining separations from the pooled TGG5 flow-through are not represented in 
the gel.  
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3.2.2. First gel filtration 
 
The pooled fractions were divided into three samples to be purified separately, the reasoning behind 
this was that if mistakes were made I would always have backups. The first sample was 15 ml and 
underwent buffer change to 20 mM imidazole and 0.1 M NaCl with concentration column (Vivaspin 
20). The sample was concentrated to 1.5 ml and was going to be used for gel filtration. I later learned 
that gel filtration changes the buffer automatically making the buffer change earlier unnecessary.      
An 0.5 ml aliquot of the sample was run through a Superdex 200 prepgrade column (1 ml was 
accidently spilled) using the ÄKTA system. UNICORN was used to record the curve, it seems like 
protein was lost through the initial buffer change and loss of the 1 ml (fig. 7). Both the contaminant 
and the TGG5 protein were collected in 2 ml fractions at a flowrate of 0.5 ml/min. A number of 
fractions were run on a SDS-PAGE mini gel with a 8-25% polyacrylamide gradient using the 
Phastsystem. These fractions corresponded to the first peak, second peak and fractions in between. No 
bands were observed on the gel probably because the fractions were too diluted (fig. 8). The fractions 
from this first gel filtration were not used for any further experiments. 
 
 
Fig. 7. The imidazole buffer of the sample gave a high background absorbance but it is still possible to observe the two 
peaks indicating the presence of the contaminant and TGG5. Gel filtration separates proteins based on differences in their 
size (roughly proportional to the molecular mass and this is the property that also allows buffer change) with the larger 
TGG5 protein (60-70 kDa) eluting before the smaller contaminant (30-40 kDa). 
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Fig. 8. Lane 1 contains the fraction before the first peak (TGG5), lane 2 contains the first peak, lane 3 has the second peak 
(contaminant), lane 4 the fraction between the two peaks, lane 5 the fraction after the second peak. Lane 6 contains 
concentrated TGG5 that have not been separated with gel filtration, and lane 7 a Low molecular weight marker used to 
approximate the molecular mass of the proteins. 
3.2.3. Second gel filtration 
 
I concentrated 10 ml of the pooled fractions to 1.5 ml for a second attempt at gel filtration but no 
buffer change was attempted as it is inherrent when running gel filtration. Two peaks were seen on the 
curve, the first one being TGG5 and the second the contaminant (fig. 9). A SDS-PAGE gel was run 
using a number of fractions but the protein was to diluted to give bands, except for a fraction 
containing the second peak (fig. 10). The first peak was fractionated into 0.5 ml fractions, thus there is 
small chance of getting a protein concentration big enough to give bands. I took the twelve 0.5 ml 
fractions making up the first peak (the small kink in the beginning not included) and concentrated it to 
1 ml and a protein concentration of 0.24 mg/ml and analysed this sample with a SDS-PAGE minigel to 
make sure the sample only contained TGG5 (fig. 11). 
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Fig. 9. The two peaks were more distinct this time with the larger TGG5 protein eluting before the smaller contaminant. 
The TGG5 protein was collected in 0.5 ml fractions while the second peak was collected in 2 ml fractions (there is no 
special reasoning behind this I just accidently set in the wrong parameters for fraction collecting). A sudden increase in 
conductivity resulted in two extra peaks occurring, most probably representing ghost peaks.   
 
 
Fig. 10. The fractions from the second gel filtration were run on minigel using the phastsystem workstation. The first lane 
has a fraction containing the contaminant (second peak), lane 2 and 3 contain TGG5 (first peak), lane 4, 5 and 6 are 
fractions from the two extra peaks (occurring close to the sudden increase in conductivity), lane 7 has the low molecular 
weight marker. Only the contaminant gave a band, the TGG5 fractions were probably to dilute to give bands. The two extra 
peaks were probably a result of  the sudden increase in conductivity and not due to presence of proteins. 
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Fig. 11. TGG5 fractions from the second  gel filtration were pooled and  loaded on the first lane of a minigel, concentrated 
TGG5 that was not submitted to gel filtration was loaded on the second gel as positive control. The third lane contains a 
low molecular weight marker. Lane four, five and six are empty. 
 
3.2.4. Hanging drop vapour diffusion crystallization 
 
The pooled fractions of the first peak acquired from the second gel filtration were further concentrated 
to 100 µl and 2.44 mg/ml. This sample was to be used for hanging drop vapour diffusion. Previous 
crystallization attempts performed with 0.2 M Litiumsulphate, 0.1 M phosphate-citrate buffer, pH 4.2 
and 20% PEG1000 had resulted in some protein crystal formation. The idea was therefore to set up 
drops around these conditions. The conditions had to be slightly modified because of availability of the 
chemicals (PEG1500 instead of 1000) and because some of the drops will contain α-mannosidase and 
α-mannosidase + endo-H. Previous experience have shown that phosphate makes the zinc needed for 
α-mannosidase to be active to fall out, therefore I changed phosphate-citrate for sodium-citrate, pH 4.2 
and in some drops pH 5.0. In total 36 drops were set up using two plates (18 drops in each plate), 12 
with only TGG5, 12 with TGG5 + α-mannosidase and 12 with TGG5 + α-mannosidase+ Endo-H. The 
drops consisted of 2.4 µl protein and 0.8 µl reservoir buffer while there was 1 ml buffer in each 
reservoir. The deglycosylation protein was 1:100 of the TGG5 protein amount. I could only observe 
the drops for 3-4 weeks but some tendencies could be observed. One is that PEG1500 concentrations 
over 15% gave precipitations, another is that LiSO4 seems to make the proteins less likely to 
precipitate. The drops containing only TGG5 did not precipitate (unless the PEG1500 concentration is 
over 15%), 4 drops containing TGG5 + α-mannosidase remained clear while all drops containing both 
deglycosylation enzymes precipitated, except one drop containing LiSO4. 
 
3.2.5. Third gel filtration 
 
The remaining 22.5 ml of the pooled TGG5 fractions were used for a third gel filtration. The same 
steps as before were taken with the separated proteins being collected in 2 ml fractions. The graph 
showed two peaks although the first peak containing the TGG5 proteins had an extra peak, it is 
probably the same as the kink seen in the second gel filtration graph although at a higher concentration 
(fig. 12). Fractions making up the first peak (TGG5), the extra peak in its vicinity and the second peak 
(30-40kDa contaminant) were separated on a SDS-PAGE minigel using the phastsystem workstation 
(fig. 13).  
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Fig. 12. The graph shows the two peaks characteristic for TGG5 and the contaminant but also a smaller third peak in 
proximity to the TGG5 peak.  
 
 
Fig. 13. Lane 1 contains the LMW marker, lane 2 contains the extra peak, lane 3 is a fraction between the extra peak and 
the first peak, lane 4, 5 and 6 are fractions of the first peak. It seems like the contaminant was not completely separated 
from the TGG5 protein (The small extra peak close to TGG5 in the third gel filtration graph is probably 30-40 kDa 
contaminant that did not separate). I would account this to a larger amount of contaminant in the sample rather then a 
difference in the gel filtration procedure. 
 
3.2.6. Optimum solubility screen (OSS) 
 
 Four fractions making up the first peak were pooled and concentrated to 100 µl and a protein 
concentration of 4.81 mg/ml. Some of this sample were to be used to set up a optimum solubility 
screen in order to test TGG5 solubility in common buffers at different pH values (table 4). 1 M buffers 
were used to reduce any effect the 20 mM Imidazole buffer of the sample might have on the test. 
Hanging drop vapour diffusion was used and the drops consisted of 0.8 µl protein and 0.8 µl reservoir 
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buffer with 50 µl buffer in each reservoir. The buffer does not seem to have any major effect on the 
protein. neither does the pH, since no precipitation was observed in any of the drops.  
 
Table4. The TGG5 protein solubility was tested in different buffers and a range of pH values.  
1M Buffer pH range 3 G 10   
Glycine pH 3.0 
Citric acid pH 3.2 
Formic acid pH 3.7 
Citric acid pH 4.0 
Na-acetate pH 4.5 
Na/K phosphate pH 5.0 
Na-citrate pH 5.5 
Na/K phosphate pH 6.0 
Bis-tris pH 6.0 
MES pH 6.2 
ADA pH 6.5 
Bis-tris-propane pH 6.5 
Cacodylate pH 6.5 
AmAc PH 7.0 
Na/K phosphate PH 7.0                              
HEPES pH 7.5 
Tris pH 7.5 
Bicine pH 8.0 
Imidazole pH 8.0 
Tris pH 8.5 
CHES pH 9.0 
CHES pH 9.5 
CAPS pH 10 
 
3.2.7. JCSGplus screen 
 
The remaining 4.81 mg/ml TGG5 sample was used to set up a JCSGplus screen which tests a large 
variety of crystallization variables. The TGG5 protein sample was mixed with 1:100 α-mannosidase 
and 1:100 endo-H before setting up the drops. No Zinc was added as it might affect the screen. Sitting 
drop vapour diffusion was used and each drop contained 0.8 µl protein and 0.8 µl reservoir buffer,     
50 µl buffer was added to each reservoir. The majority of the drops were either precipitated or clear  
except one of the drops in calcium chloride, 0.1 M bis-tris, pH 5.5 and 45% MPD. This drop contained 
a very small crystal of about 60 x 20 micrometer (fig. 14). 
 
 
Fig. 14. A small crystal found in the JCSGplus screen. 
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3.3. TGG5 Molecular mass estimation using mass spectrometry 
 
I wanted to do a rough molecular mass estimation of TGG5 before and after α-mannosidase and endoH 
deglycosylation. The MALDI-TOF procedure was going to be performed by Åke Engström and he 
preferred to have the proteins separated on a SDS-PAGE gel. TGG5 concentrated to 2.44 mg/ml was 
used to set up hanging drops: 1 µl with only TGG5, 1µl with 1:100 α-mannosidase and 1 µl with 1:100 
α-mannosidase + 1:100 endoH. The protein was in its original 20 mM imidazole and 0.1 M NaCl 
buffer and 1 ml of this buffer was also added to the reservoir. The drops were incubated at 20°C for 6 
days before being separated on a minigel using the Phastsystem (fig. 15). The gel was sent to Åke 
Engström for mass spectrometry. He was not able to estimate the mass from the samples on the gel and 
requested liquid samples for the three samples. I never threw anything away and was able to give him 
5 µl TGG5, 4 µl TGG5 + α-mannosidase and 5 µl α-mannosidase + endoH. The deglycosylation 
enzymes still have a 1:100 ratio but the origin of the samples was hard to pinpoint. Åke was able to 
acquire mass spectrums from the TGG5 and the TGG5 + α-mannosidase samples but there was too 
much disturbances in the sample containing EndoH to give any mass spectrum. In the data from the 
TGG5 sample, two peaks could be seen very close together, the larger peak had the molecular mass 
65.4 kDa and the smaller peak 63.6 kDa (fig. 16). The mass spectrum of the TGG5 + α-mannosidase 
gave only one peak with a molecular mass of 64.4 kDa (fig. 17), thus α-mannosidase must have 
trimmed of about 1 kDa of mannosidase glycans, the extra peak might have been a different 
glycosylation form of the TGG5 protein as its very common that proteins have heterogenous 
glycosylation (Daly & Hearn 2005). This might explain the double bands that sometimes occur on 
SDS-PAGE gels and some of the difficulties experienced when trying to crystallize the protein. 
 
 
 
Fig. 15. Lane 1 contains the contaminant (to be used in another experiment), lane 2 contains concentrated TGG5 (before gel 
filtration), lane 3 contains a LMW marker, lane 4 contains TGG5, lane 5 contains α-mannosidase treated TGG5 while lane 
6 contains TGG5 that had been treated both with α-mannosidase and EndoH. The contaminating band in lane 6 is probably 
EndoH as it corresponds to EndoH’s Molecular mass of  28.5 kDa. 
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Fig. 16.  The larger 65.4 kDa peak is presumed to be the TGG5 protein and the smaller 63.6 kDa peak might  represent  a 
different glycosylation variant of the same protein.  
 
 
Fig. 17. The mass spectrum of the α-mannosidase treated TGG5 gave a 1 kDa reduction in the molecular mass  (65.4 kDa 
→ 64.4 kDa). The 63.4 kDa peak is absent in the mass spectrum and my guess is that it was trimmed to 62.4 kDa and 
became undistinguishable from the noise in the mass spectrum. 
. 
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3.4. Determination of the identity of the contaminant 
 
A series of experiments were done to determine the identity of the 30-40 kDa contaminant, the 
experiments included western blot analysis, alcohol oxidase assays, gel filtrations, SDS-PAGE and 
MALDI-TOF to estimate the mass and peptide mass fingerprinting. 
3.4.1. Western blot analysis 
 
Western blotting was performed using a TGG5 sample with myrosinase activity and a primary 
polyclonal antibody with histidine affinity was used to bind the 6xhis tag of the recombinant TGG5 
protein. An HRP conjugated secondary antibody was used to bind the primary antibody and allow 
visualization. When visualized it did not seem like there was any TGG5 present to bind to, but 
unexpectedly the his-binding antibody bound to the 30-40 kDa contaminant. When running the gel a 
magic marker was used. 
3.4.2. Enzyme assay of alchohol oxidase 
 
The contaminant has been hypothesized to be AOX1, a protein highly abundant when P. pastoris is 
grown with methanol as the only carbon source. I decided to test the activity of fractions acquired from 
the IMAC purification containing both the TGG5 protein and the 30-40 kDa contaminant. The same 
test was also performed on fractions acquired from gel filtration where the TGG5 protein and the 
contaminant were purified into individual fractions. A crude extract of proteins from P. pastoris was 
used as positive control as it was assumed to contain AOX1. A sample with 100 mM potassium 
phosphate buffer instead of protein was used as a negative control. The colorimetric assay used to 
measure the alcohol oxidase activity quickly overshoot in the crude extract while no activity was 
observed in any of the other samples (table 5). Therefore it is hihly unlikely that the contaminant is an 
alcohol oxidase enzyme.     
 
Table 5. Triplicates were made for every sample and the contaminant was tested at a lower (2 µl) and a higher 
concentration (10 µl). TGG5 (I) is a sample consisting of all pooled fractions from an IMAC purification, while a 
concentrated first peak contained only TGG5. When measured at 405 nm for absorbance it is quite clear that there is no 
alcohol oxidase activity whatsoever. 
Sample Absorbance (405nm) 
Concentrated second peak (2 µl) -0.026 
Concentrated second peak (2 µl) 0.012 
Concentrated second peak (2 µl) -0.001 
Concentrated second peak (10 µl) -0.031 
Concentrated second peak (10 µl) -0.039 
Concentrated second peak (10 µl) -0.039 
TGG5 (I) (2 µl) -0.026 
TGG5 (I) (2 µl) 0.012 
TGG5 (I) (2 µl) -0.001 
TGG5 Crude extract (2 µl) 3.339 
TGG5 Crude extract (2 µl) 3.339 
TGG5 Crude extract (2 µl) 3.339 
Concentrated first peak (2 µl) -0.026 
Concentrated first peak (2 µl) 0.012 
Concentrated first peak (2 µl) -0.001 
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3.4.3. MALDI-TOF 
 
A contaminant containing fraction was run on a SDS-PAGE minigel using a Phastsystem and sent for 
mass estimation and peptide mapping (fig. 15). The mass was estimated to approximately 37 kDa (fig. 
18) correlating quite well with the mass estimated from the SDS-PAGE minigels (e.g. fig. 15). The 
contaminant was also peptide mass fingerprinted and the data was run up against the Mascot database 
but no protein was found in the database. Åke Engström performed de novo sequencing on the 
contaminant translating three peptides into their amino acid sequence (table 6). These three peptide 
sequences were Blasted and they all gave the same result; Mitochondrial alcohol dehydrogenase 
isozyme III. The alignment was more or less 100%. Therefore the contaminant most likely represents  
an alcohol dehydrogenase isozyme. 
 
 
Fig. 18. The mass of the contaminant was estimated to 37 kDa using MALDI-TOF. 
 
 
Table 6. Translated amino acid sequences. 
Sequence 1  VYEQMEAGAIIGR 
Sequence 2 ADISGFTHDGSFQQYATADATQAAR 
Sequence 3 AINQSVQYVR 
 
 
3.5. Myrosinase mutant activity studies - first attempt 
 
Five mutants of TGG4; E418A, E418H, S214A, I278A, E418Q and a TGG4 wild type were sample 
prepared for separation by immobilized metal-ion affinity chromatography (IMAC). The separations 
were carried out at room temperature although the samples and all elution buffers were kept on ice. 
Out of these the S214A mutant was too unstable to give good readings while the E418H and I278A 
mutants were only stable enough to be tested once for myrosinase activity using sinigrin (S-β-
glucoside) as a substrate. The TGG4 wild type and E418Q mutant were stable enough to be tested for 
myrosinase activity using sinigrin and pNPG a substrate usually hydrolysed by the O-β-glucosidases. 
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An attempt was made on testing how different concentrations of ascorbate affect the myrosinase 
enzymatic activity but the results were very dubious and will not be described furher. The mutants 
were made in previous experiments by other members of the laboratory. I merely used the cell pellet of 
the mutants for myrosinase activity studies. 
 
3.5.1. Myrosinase activity using sinigrin as substrate 
 
The myrosinase activity of the mutants was tested using sinigrin, a S-β-glucoside, and the myrosinase 
activity calculated as mmol glucose released per minute (Units/ml) as glucose, sulfate and an aglycone 
is released when sinigrin is hydrolysed. The glucose will only be read as total activity because the 
samples contained the 30-40 kDa contaminant and it was uncertain how large part of the total protein 
concentration was due to the contaminant. The TGG4 wt, E418Q, E418H and I278A had a total 
activity of 32.8, 17,11.5 and 0.87 units/ml, respectively. It seems like the change of the glutamate 
active site to glutamine and histidine did not take away all activity while a change in isoleucine, a 
proposed aglycone binding site, gave a big reduction in activity (fig. 19). 
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Fig. 19. The activity as mmol glucose/min was converted to percent activity setting the wt as 100% and comparing the 
mutants with the wild type activity. The E418Q mutant showed  only 52% activity while the E418H mutation had 35% of 
the wt myrosinase activity. The I278A mutation had the biggest loss of activity giving only 3% of the normal activity. 
 
3.5.2. O-β-glucosidase activity using pNPG as substrate 
 
pNPG is an O-β-glucoside and commonly hydrolysed by O-β-glucosidases. Out of the mutants only 
the TGG4 wt and the E418Q mutant were stable enough to be further tested. The assay is similar to the 
myrosinase assay with the difference that the amount of free aglycone is measured at 405nm as 
released p-nitrophenol and converted to mmol p-nitrophenol/min. TGG4 gave 1.56 units/ml while the 
E418Q mutant gave 5.91 units/ml, thus the enzymatic activity in the mutant was increased almost four-
fold by substituting the glutamate residue with glutamine (fig. 20). 
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Fig. 20. The activity in mmol p-nitrophenol/min was converted to relative activity setting the wild type activity as 100 
percent. The mutant had 379% activity and was thus 279% more active then the wild type.  
 
3.6. Mutant myrosinase activity studies – second attempt 
 
Mutants used in the previous experiment were grown in 10 ml BMGY in 50 ml falcon tubes. The 
BMGY was removed and the mutants were expressed in 10-15 ml BMMY in 50 ml falcon tubes. The 
reason I grew the mutants in falcon tubes was that earlier I had experienced problems with 
contamination and smaller volumes are easier to keep sterile. The seven mutants grown were K218A, 
E418D, S214A, F475A, Q211E, Q211A and E418A. All these mutants were sample prepared and the 
protein purified using IMAC. A TGG4 wild type sample prepared in previous experiment was taken 
from a -20°C freezer, sample prepared and purified in the same manners as for the mutants. The IMAC 
procedure was performed at 4°C as it seems the myrosinase protein becomes unstable when purified at 
room temperature. When separating the proteins on a SDS-PAGE gel it seems like very little protein 
bound to the column (fig. 21). All mutants were stable enough to be tested for myrosinase activity with 
both sinigrin and pNPG as substrate. The potential enzymatic activation by ascorbate was tested using 
sinigrin as substrate. The total activity of the myrosinase was used because the sample was not pure 
enough to give a protein concentration specific for myrosinase.  
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Fig. 21. From left to right the following samples are present; K218A, E418D, S214A, F475A, Q211E, Q211A, E418A, 
TGG4 (WT), unrelated sample and the marker. The bands are weak indicating that there is very little protein in the sample. 
The good news is that the mutants seem to have a similar amount making them more comparable. 
 
3.6.1. Myrosinase activity using sinigrin as substrate 
 
Like the first attempt, sinigrin was used as the substrate and the amount of released glucose was 
measured at 550nm and the absorbance value converted to mmol glucose/min. TGG4 wt, F475A, 
S214A, Q211A, E418D, Q418E, K218A, and E418A mutant had an activity of 18.3, 10.7, 3.15, 1.51, 
7.26, 5, 6.3 and 1 mmol glucose/min. The F475A and E418D mutant retained more or less half their 
activity while the E418A and Q211A mutants lost almost all their activity. The three remaining 
mutants (S214A, Q211E and K218A) had activities ranging between 17-35% of the original activity 
(fig. 22). 
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Fig. 22.  From the graph it seems like F475A, E418D and K218A retained most of their activity at 58%, 40% and 35% 
respectively. S214A and Q211E mutants formed an intermediate group at 27% and 17%, while Q211A and E418A retained 
the least activity at 8% and 5%, respectively. 
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3.6.2. O-β-glucosidase activity using pNPG as substrate 
 
An activity assay performed using pNPG as substrate showed that all mutants except Q211E and 
E418D had activity.TGG4 wt, E418A, S214A, F475A, Q211A and K218A, showed an total activity of  
0.47, 0.14, 0.2, 0.28, 0.3, and 0.31 mmol p-nitrophenol/min, respectively. These are values 
considerably lower than when using a S-β-glycoside, the natural substrate of myrosinases. When 
converting the values into percent activity it also seems like the difference between the mutants and the 
wild type is less than with sinigrin with F475A, Q211A and K218A giving a little more then half the 
activity of the wild type, and E418A and S214A giving a little less then half (fig. 23). 
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Fig. 23.  The three mutants F475A, Q211A and K218A have a similar activity at 60%, 64% and 66%, respectively. E418A 
and S214A have a little less activity at 30% and 43%, respectively. 
 
3.6.3. Myrosinase activity using sinigrin as substrate with addition of ascorbate  
 
Ascorbate is a co-factor in the myrosinase enzyme and can increase the myrosinase activity at certain 
concentrations. This increase in activity varies with different myrosinases. The TGG4 wild type and all 
the mutants were tested for myrosinase activity using sinigrin as substrate and different concentrations 
of ascorbate. The ascorbate solution was prepared right before every assay and samples, sinigrin and 
ascorbate were pre-heated before the assay. The ascorbate concentrations used were 0.115, 0.46, 1.1, 
1.8 and 2.64 mM. It is the glucose released upon sinigrin hydrolysis that is measured at 550nm and 
converted to mmol glucose/min. This value was converted to percent activity using TGG4 wt as 100% 
(fig. 24). The values were also converted to percent activity using the mmol glucose/min values 
received when performing the assay without addition of ascorbate having this basal value as 100% 
(fig. 25).  
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Fig. 24. When looking at the graph it is noticeable that E418D has a higher activity then the wild type even reaching 120% 
at 1.8mM thus being 20% more active then the wild type. Q418E is another active mutant reaching 91-92% while K218A, 
S214A and F475A are stuck between 50 and 80%. Q211A and E418A are still the least active mutants only reaching 
between 10-40% activation. 
 
    
 
 
             
 
 
 
 
 
 
 
 
 
 
 
Fig. 25.  Another way to measure the activation by ascorbate is to set the activity reached in the absence of ascorbate to 
100% and then add the activity gained under the influence of ascorbate. When measured like this it seems like the wild type 
is the least activated form only reaching 251% activation at its highest point of 0.46 mM ascorbate. The most activated are 
instead E418A and Q211A both reaching over 1000% . 
 
4. Discussion 
 
4.1. TGG5 crystalization attempt 
 
A P. pastoris GS115 strain had been transformed in previous experiments to contain a TGG5 gene 
expressed behind the AOX promoter known to be one of the strongest promoters in nature (Ozimek et 
al. 2005). The resulting recombinant strain was grown in BMGY media to gain mass and switched to 
BMMY media to express the recombinant protein. Being a methylotropic yeast, P. pastoris is capable 
to grow on media containing methanol as the only carbon source. It is important to keep the methanol 
level at 0.5% and new methanol is thus added on a daily basis to make up for methanol consumed and 
methanol evaporated. However it is important to not get carried away as even a concentration 
exceeding 3% might be detrimental (Murray et al. 1989). The recombinant TGG5 protein had a 6xhis 
tag engineered at its N-terminal making immobilized metal-ion affinity chromatography (IMAC) an 
ideal purification step. Purification with IMAC is not sufficient to obtain a pure protein since a 30-40 
kDa contaminant (later identified as a alcohol dehydrogenase isozyme) co-eluted with TGG5.  
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Ion-exchange chromatography was used to separate TGG5 and the contaminant but resulted in quite 
low concentration of the protein, probably due to the buffer exchange step. This was enough to be 
concentrated into a concentration more suited for crystallization but I also wanted to deglycosylate the 
TGG5 protein to make it more homogenous and hopefully easier to crystallize. Some protein was lost 
due to phosphate and zinc precipitating during enzymatic deglycosylation with α-mannosidase and 
when trying to separate the glycans from TGG5 with ion-exchange chromatography, the rest of the 
protein was lost.  
 
I made a second attempt to purify TGG5 but was running short on time. Therefore I used TGG5 cell 
pellets stored at -20°C for purification with IMAC. In contrast to the last time I performed the IMAC 
step at 4°C instead of room temperature because I was hoping to get a more stable preparation. 
Although the proteins might have become more stable it seemed like a lot of the TGG5 protein did not 
bind to the column as seen on SDS-PAGE gels, containing the elution samples, crude extract and flow-
through. It might be that the proteins adopt a different structure at 4°C making the his-tag less exposed 
and thus less likely to bind. To remove the contaminant I used gel filtration chromatography mostly 
because this chromatography method automatically changes the buffer of the samples. I divided my 
protein into three samples to be purified individually because I did not want to loose all protein due to 
any accident. The sample used for the first gel filtration was lost because of an accident when loading 
the sample into the ÄKTA-system, the second and third attempt were more successful. The sample 
acquired at the second attempt was used to set up hanging drop for vapour diffusion crystallization. 
The sample was concentrated to 2.44 mg/ml, a concentration not very ideal for crystallization but I 
gave it a try anyway. The crystals were set up around conditions that Eva-Lena Andersson used as 
these resulted in some crystals although not big enough to give a molecular structure of TGG5. The 
conditions she used were 0.2 M litiumsulphate, 0.1 M phosphate-citrate buffer, pH 4.2 and 20% PEG 
1000. Some adjustment had to be made because I was going to include 1:100 α-mannosidase in some 
drops and 1:100 α-mannosidase + 1:100 EndoH in other drops and from previous experiments it was 
concluded that zinc falls out in the presence of phosphate, zinc being necesseray for α-mannosidase to 
reach full activity. Therefore the phosphate-citrate buffer was changed to sodium-citrate buffer. The 
PEG1000 was also changed to PEG1500  because PEG1000 was not available. No crystals were 
observed but it seemed like the presence of α-mannosidase did not make the protein precipitate. All 
drops containing EndoH (except one) precipitated but if this is because TGG5 become unstable due to 
the loss of the glycan side-chains or the presence of EndoH was not clear. The only drop containing 
EndoH that did not precipitate was the one containing LiSO4. It is possible that the sulphate group 
confers some kind of stability to the myrosinase enzyme considering that it binds the sulphate group of 
its natural substrate (glucosinolates). The TGG5 sample from the third gel filtration was concentrated 
to 4.81 mg/ml and used to set up a buffer screen (optimum solubility screen) and a screen to test 
various crystallization variables. For the buffer screen, hanging drops of TGG5 were set up using 1 M 
buffers with a pH ranging from 3-10. No precipitation was observed suggesting that a wide variety of 
buffers and pH values can be used when purifying the protein without a major loss due to precipitation. 
In the JCSGplus screen, TGG5 was mixed with 1:100 α-mannosidase and 1:100 EndoH but no zinc 
was added. A small crystal was observed in the drop containing calcium chloride, 0.1 M bis-tris, pH 
5.5 and 45% MPD. It is uncertain if the crystal is a protein, considering the involvement of calcium 
chloride it might be a salt.  
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4.2. TGG5 molecular mass estimation 
 
When expressing TGG5 in P. pastoris the protein gets glycosylated with N-linked mannose residues 
giving the protein a molecular mass different from the 57.469 kDa molecular mass that the 511 amino 
acids would give. An attempt was made to get an estimate of the molecular mass of the glycosylated 
TGG5 after treatment with α-mannosidase and after treatment with both α-mannosidase and EndoH. 
These samples were used for MALDI-TOF mass spectrometry, first as bands separated on a SDS-
PAGE minigel and when that did not work, as liquid samples. A molecular mass of 65.4 kDa was 
estimated for the glycosylated TGG5, although a smaller peak of 63.6 kDa was found in very close 
proximity to the 65.4 kDa peak. This extra peak might be a differently glycosylated form of TGG5 as 
two bands have been spotted before when separating TGG5 on SDS-PAGE gels and it is not 
uncommen that proteins undergo heterogeneous glycosylation. The α-mannosidase treated TGG5 had a 
molecular mass of 64.4 kDa and thus trimmed away 1 kDa of N-linked glycans from the protein. Only 
one peak was present and this could mean that either the protein was more homogenously glycosylated 
or that trimming away 1 kDa of N-linked glycans made the mass spectrometer unable to register it (as 
it already was a very small peak). No mass spectrum was recorded for the TGG5 protein treated with 
both α-mannosidase and Endo-H. 
 
4.3. Determination of the identity of the contaminant 
 
When trying to purify the TGG5 protein expressed using the Pichia expression kit a very abundant 38 
kDa contaminant was encountered. This contaminant was first presumed to be a degraded form of the 
AOX gene as it is the protein most abundant when P. pastoris is grown on methanol containing media. 
Although this seemed a bit farfetched when the AOX protein is known to give 72 kDa bands (Ellis et 
al. 1985) and occurs as a octameric protein (Higgins & Cregg 1998) it is unlikely that all eight subunits 
would get degraded. Thus after the IMAC purification step I performed a colorimetric AOX assay to 
confirm whether any alcohol oxidase was present. All fractions from the IMAC purification gave 
negative results. Earlier I had also performed a western blot analysis using primary anti-his antibodies 
and found that they bound to the 38 kDa band, thus I formed a new theory that this contaminant was 
actually a degraded TGG5 subunit containing the his-tag. But an abundant ~ 40 kDa protein has been 
encountered before when purifying proteins from P. pastorsis (Ellis et al. 1985). One report even 
found out that it had nickel affinity making it stick to IMAC columns (Law et al. 2001). This nickel 
affinity could explain the difficulties in removing the 38 kDa contaminant using IMAC. When 
removing contaminants with IMAC it would probably be a good idea to use washing buffer with 
higher imidazole concentration since the his-tagged protein should bind stronger than the contaminant 
and be less eluted.  
The contaminant was further characterized by running the samples through gel filtration separating 
TGG5 and the contaminant running the contaminant as shown by SDS-PAGE. The contaminant was 
then used for mass estimation and peptide mass fingerprinting. The contaminants mass was estimated 
to 37 kDa correlating well with the molecular mass observed upon SDS-PAGE. I also received three 
peptide sequences from peptide mass fingerprinting. When running a BLAST on these sequences a 
100% correlation to mitochondrial alcohol dehydrogenase isozyme III, a 350 amino acids long protein 
of P. pastoris, was found. An alcohol dehydrogenase was also found by another lab group and they 
correlated the ubiquitous nature to its role in detoxifying methanol (Law et al. 2001). However, a 40 
kDa protein has also been observed when P. pastoris was grown on ethanol but it is unknown if it is 
the same alcohol dehydrogenase and not another isozyme (Ellis et al. 1985).  
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4.4.1. Mutant myrosinase activity studies 
 
Mutants created in previous experiments were expressed in P. pastoris and purified by IMAC, first at 
room temperature, but when it seemed to make the enzyme unstable I switched to 4°C. 
The mutants were tested for enzymatic activity using both sinigrin (S-β-glucoside) and pNPG (O-β-
glucoside) as substrate. The mutants were also tested by addition of different concentrations of 
ascorbate using sinigrin as substrate. The mutation sites where chosen based on conserved residues 
found in the 1E71 crystal structure of myrosinase from Sinapsis alba (Bourderioux et al. 2005; see also 
alignment in appendix 3) 
 
The Glutamine residue replacing the glutamate normally found in β-glucohydrolases (see appendix 3) 
is believed to be involved in binding of the sulphate group in glucosinolates as well as ascorbate, it is 
also believed to be crucial for the positioning of the water molecule allowing hydrolysis of the 
substrate.  
 
Q211E is a mutation that replaces the glutamine residue for glutamate thus resembling the acid/base 
complex of O-β-gucosinolates. But it does not seem like having a full acid/base pair gives any 
advantage as the enzyme activity was only a third when using sinigrin as a substrate and not 
measurable using pNPG. The loss of glutamine might make it harder for the enzyme to position the 
water molecule accurately. Another possibility is that the myrosinase has problem binding the 
substrate with glutamate due to unfavourable charges (both glutamate and the sulphate group are 
negatively charged). Some of the activity was restored when ascorbate was added (80% of wt activity) 
maybe because the ascorbate molecule helped with the positioning of the water molecule or binding of 
the substrate.  
 
An Q211A mutant was also tested, the alanine mutation being a way to replace an important residue 
with a small and uncharged residue. The activity assay using sinigrin gave as expected very low 
activity, only a tenth of the wild type activity. A higher activity was reached when pNPG was used as 
substrate, giving 64% activity. When having ascorbate added, the Q211A mutant reached only 37% of 
the full activity (100% being the activity the wild type had at the same ascorbate concentration). This 
suggests that the glutamine residue is very important for the myrosinase to function properly but I do 
not know if it is the reduced ability to bind the SO4/ascorbate or the positioning of the water molecule 
that is responsible for the low activity of the mutants. I can not explain why it had higher activity when 
pNPG was used as a substrate either.  
 
E418Q is a mutation that replaces the acid residue of the catalytic site to glutamine. When testing the 
activity using sinigrin as substrate, the activity was halved, an expected result as glutamate is involved 
in the catalytic activity. An unexpected result when using pNPG (O-β-glucoside) was that the activity 
was almost threefold the activity of the wild type. If you compare this with the Q211E mutant, where a 
glutamine was changed to glutamate, and the absence of activity that followed, it almost seems like 
glutamate makes it harder for the myrosinase to hydrolyse O-β-glucosides.  It is possible that 
glutamate makes it harder for the protein to position the water molecule for hydrolysis. Another 
explanation is that glutamate hinders binding of the substrate, either sterically or by its negative 
charge. I was not able to perform an ascorbate assay on this mutant, therefore no data for its interaction 
with ascorbate is available. 
 
Aspartic acid and histidine are much like glutamic acid, common amino acids in active sites much due 
to their ability to change their charge depending on the environment and act as either proton donors or 
proton acceptors. Glycosyl hydrolases using aspartic acid as proton donors have been encountered 
although the same can not be said about histidine. Nevertheless, two mutants were tested, E418D and 
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E418H, replacing the glutamic acid with either aspartate or histidine. When testing these two mutants 
for myrosinase activity using sinigrin as substrate they both gave an activity around 40%. This might 
mean that even if histidine is not a natural residue in glycosyl hydrolases it does confer some activity.  
 
The E418H mutant was purified by IMAC at room temperature. This made the mutant very unstable 
and it lost all its activity within one day making any further tests impossible. The E418D mutant was 
tested for activity using pNPG as a substrate, but much like the Q211E mutant no activity was 
measured. Thus it might be that the negatively charged side chain of the glutamate and aspartate 
residue is interfering with binding of the substrate. The E418D mutant was tested for enzymatic 
activity under addition of ascorbate using sinigrin as substrate. Surprisingly enough the enzymatic 
activity was higher than for the wild type and at some point even gave 20% higher activity than the 
wild type.  
 
E418A is a mutation that replaces the proton donor with the non-reactive alanine. Both the assay using 
sinigrin and sinigrin with ascorbate gave low activity. If you compare it with the results from the 
E418D mutant it seems like ascorbate can restore the activity as long as there is an available proton 
donor. The E418A mutant had some activity using pNPG as a substrate and I guess the aspartate of the 
E418D mutant made it unable to use pNPG as substrate.  
 
The Serine 214 residue is believed to bind the sulphate group of the glucosinolate and establishing 
hydrogen bonds together with other residues (e.g. Gln211 and Lys218). The S214A mutant had very 
low activity (17% of normal wt activity) using sinigrin as substrate and 43% of wt activity using pNPG 
as substrate. This is probably due to an inability to bind the SO4 group and it might also affect the 
ability of other residues to bind the sulphate group.  
 
The lysine residue corresponding to the Arg 194 residue in 1E71 is believed to have a weak interaction 
with the SO4 group (through a positive charge). The K218A mutant had 35% of wt activity using 
sinigrin and 66% using pNPG. I guess that because the interaction is believed to be weak it does not 
affect the binding of SO4 as strongly as the S214A mutation. The lysine residue is believed to only 
play a weak electrostatic role when binding to ascorbate but still the K218A mutant loses ~ 30% 
activity when using sinigrin as substrate with addition of ascorbate. 
 
Phe 475 is located in the wall of the glucosyl binding site nearest to the 3-hydroxyl of the glucose 
residue. The F475A mutant had 58% of wt activity using sinigrin as substrate and 60% using pNPG. In 
presence of ascorbate it had lost ~ 30% activity. One edge of the phenyl ring of Phe 475 is in contact 
with the 3-hydroxyl of the glucose moiety, while the rest of the sidechain is buried in the wall of the 
glucosyl binding site where it fits snugly. When mutated to alanine, the sidechain will not fill up the 
hole and may not be as firmly fixed in position. This may destabilise the polypeptide chain in this 
region and affect adjacent amino acids like the preceding residue, Glu 466, that is helping to position 
the glucosyl unit by hydrogen bonding to its 6- and 4-hydroxyls. As a consequence the mutation is 
likely to primarly affect the binding of the glucosyl unit of the substrate. Ascorbate binds > 9 Å away 
from the Phe 475, but could be affected by more distant effects of structural perturbations caused by 
the mutation. 
 
The isoleucine 278 residue forms a hydrophobic surface together with tyrosine and phenylalanine that 
interacts with the SO4 group. The I278 mutant was purified by IMAC at room temperature and was 
therefore very unstable, I managed to get a reading of 3% activity compared to wt but I do not know if 
this low activity is due to the mutation or the instability of the myrosinase. Ile 278 is also believed to 
interact with the ascorbate co-factor but the unstable mutant could not be tested for myrosinase activity 
under addition of ascorbate. 
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4.4.2 Ascorbate vs sinigrin 
 
The sinigrin was always used at 12.5 mM while the ascorbate concentrations used were 0.115, 0.46, 
1.1, 1.8 and 2.6 mM, respectively. From the experiments it seemed like the 0.46 mM ascorbate 
concentration gave the highest catalytic activity for the K218A, E418D, Q211A, E418A and wild type. 
The F475A mutant showed a similar activation as for the Q418E mutant at both 0.46 and 1.1 mM 
ascorbate. The S214A differed from the other mutants in that its highest activation was reached at 1.1 
mM ascorbate. The Q211A and E418A mutants both lost activity quickly when higher concentrations 
of ascorbate was added, with Q211A losing all activity at 1.8 mM and E418A at 2.6 mM. The wild 
type differed from most mutants in that it reached a high activation at 0.115 mM ascorbate and only a 
slight increase in catalytic activity at 0.46 mM. The highly activated E418D was similar to Q211A and 
E418A in that its catalytic activity increased greatly between 0.115 mM and 0.46 mM. The K218A on 
the other hand differed in that it lost less catalytic activity when higher ascorbate concentration was 
used (appendix 4). 
 
5. Conclusions 
 
The crystallization was not very successful, but for further crystallization attempts it can be noted that 
gel filtration similar to ion exchange chromatography, gives a good separation of TGG5 and the 
contaminant and makes buffer exchange unnecessary. It also turned out that TGG5 is stable in a broad 
spectrum of buffers. Perhaps two-dimensional polyacrylamide gel electrophoresis could be performed 
to assure that only TGG5 remains after purification. The conditions yielding the small crystal should 
be used for further protein crystallisation attempts, assuming the crystal is a genuine protein crystal 
and not a salt crystal. The crystal is too small for x-ray diffraction experiments on the in-house x-ray 
diffractometer at BMC. It may hopefully be possible to test the crystal at a powerful synchrotron 
radiation source (e.g. ESRF, Grenoble, France) in a near future.When crystallizing the protein, LiSO4 
could be added to avoid TGG5 precipitation as it seemed to have a stabilizing effect, if another attempt 
at mass estimation is made ion-spray mass spectrometry could be an alternative to MALDI-TOF as it 
may result in less noise. From the mutant studies it was observed that most of the mutants were 
capable of hydrolysing pNPG although not very efficient. The only exceptions were Q211E and 
E418D that were incapable to hydrolyse any pNPG. Among the mutants, Q211A, E418A and S214A 
had the greatest reduction in catalytic activity,.Q211A and E418A are already known to be important 
residues based on the 1MYR structure but it seems like S214A and its proposed sulphate-group 
binding ability is also quite important. The ascorbate co-factor proved to be very effective in 
increasing the catalytic activity of the mutants with the E418D mutant even exceeding the activity of 
the wild type. Some of the mutants seemed to have acquired a changed stimulating-inhibiting reaction 
to ascorbate compared to the wild type. This changed inhibiting-stimulating relation could be further 
tested by using other ascorbate concentrations and ascorbate analogs. The mutant activity studies 
should be repeated to make sure the result is reproducible and also to obtain the Vmax and Km values. 
The IMAC procedure should be performed at 4°C as room temperature seemed to be detrimental to the 
mutant protein. By increasing the imidazole concentration in the washing buffer (e. g. 100 mM) an 
attempt to remove the contaminant could be made making further purification steps unnecessary. Gel 
filtration and ion-exchange could further purify the protein, allowing observation of specific activity 
instead of total activity, although there is a risk that the mutant protein will not survive the purification.   
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APPENDIX 1 
 
BLAST results of contaminant protein partial sequences 
 
>emb|CAY69102.1|  Mitochondrial alcohol dehydrogenase isozyme III [Pichia pastoris  
GS115] 
Length=350 
 
 Score = 45.6 bits (100),  Expect = 6e-04 
 Identities = 13/13 (100%), Positives = 13/13 (100%), Gaps = 0/13 (0%) 
 
Query  1    VYEQMEAGAIIGR  13 
            VYEQMEAGAIIGR 
Sbjct  331  VYEQMEAGAIIGR  343 
 
 
>emb|CAY69102.1|  Mitochondrial alcohol dehydrogenase isozyme III [Pichia pastoris  
GS115] 
Length=350 
 
 Score = 76.6 bits (173),  Expect = 3e-13 
 Identities = 24/25 (96%), Positives = 25/25 (100%), Gaps = 0/25 (0%) 
 
Query  1    ADISGFTHDGSFQQYATADATQAAR  25 
            AD+SGFTHDGSFQQYATADATQAAR 
Sbjct  117  ADLSGFTHDGSFQQYATADATQAAR  141 
 
 
>emb|CAY69102.1|  Mitochondrial alcohol dehydrogenase isozyme III [Pichia pastoris  
GS115] 
Length=350 
 
 Score = 35.4 bits (76),  Expect = 0.68 
 Identities = 10/10 (100%), Positives = 10/10 (100%), Gaps = 0/10 (0%) 
 
Query  1    AINQSVQYVR  10 
            AINQSVQYVR 
Sbjct  254  AINQSVQYVR  263 
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APPENDIX 2 
 
TGG4 mutations based on the 1E71 crystal structure from Sinapsis alba 
 
TGG4            MAIPKAHYSLAVLVLLFVVVSSSQKVCNPECKAKEPFHCDNTHAFNRTGFPRNFTFGAAT 60 
TGG5            MAIPKAHYSLAVLVLLFVVVSSSQKVCNPECKAKEPFHCDNTHAFNRSGFPKNFTFGAAT 60 
1E71            ----------------------DEEIT---CQENLPFTCGNTDALNSSSFSSDFIFGVAS 35 
                                      .:::    *: : ** *.**.*:* :.*. :* **.*: 
 
TGG4            SAYQIEGAAHRALNGWDYFTHRYPEK-VPDRSSGDLACDSYDLYKDDVKLLKRMNVQAYR 119 
TGG5            SAYQIEGAAHRALNGWDYFTHRYPEK-VPDRSSADLACDSYDLYKDDVKLLKRMNVQAYR 119 
1E71            SAYQIEGTIGRGLNIWDGFTHRYPNKSGPDHGNGDTTCDSFSYWQKDIDVLDELNATGYR 95 
                *******:  *.** ** ******:*  **:...* :***:. ::.*:.:*..:*. .** 
 
TGG4            LSIAWSRVLPKGRLTGGVDENGITYYNNLINELKANGIEPYVTIFHWDVPQTLEDEYGGF 179 
TGG5            LSIAWSRVLPKGRLTGGVDENGITYYNNLINELKANGIEPYVTIFHWDVPQTLEDEYGGF 179 
1E71            FSIAWSRIIPRGKRSRGVNEKGIDYYHGLISGLIKKGITPFVTLFHWDLPQTLQDEYEGF 155 
                :******::*:*: : **:*:** **:.**. *  :** *:**:****:****:*** ** 
 
TGG4            LSTRIVEDYTNYAELLFQRFGDRVKFWITLNQPFSLATKGYGDGSYPPGRCTG----CEL 235 
TGG5            LSTRIVEDYTNYAELLFQRFGDRVKFWITLNQPLSLALKGYGNGSYPPGRCTG----CEL 235 
1E71            LDPQIIDDFKDYADLCFEEFGDSVKYWLTINQLYSVPTRGYGSALDAPGRCSPTVDPSCY 215 
                *..:*::*:.:**:* *:.*** **:*:*:**  *:. :***..  .****:     .   
 
TGG4            GGDSGVEPYTVAHNQLLAHAKTVSLYRKRYQKFQGGKIGTTLIGRWFAPLNEFSELDKAA 295 
TGG5            GGDSGVEPYTVAHNQLLAHAKTVSLYRKRYQKFQGGKIGTTLIGRWFVPLNEFSELDKAA 295 
1E71            AGNSSTEPYIVAHHQLLAHAKVVDLYRKNYT-HQGGKIGPTMITRWFLPYNDTDRHSIAA 274 
                .*:*..*** ***:*******.*.****.*  .******.*:* *** * *: .. . ** 
 
TGG4            AKRAFDFFVGWFLDPLVYGKYPTIMREMVGDRLPEFTPEQSALVKGSLDFLGLNYYVTQY 355 
TGG5            AKRAFDFFVGWFLDPLVYGKYPTIMREMVGDRLPEFTPEESALVKGSLDFLGLNYYVSQY 355 
1E71            TERMKEFFLGWFMGPLTNGTYPQIMIDTVGERLPSFSPEESNLVKGSYDFLGLNYYFTQY 334 
                ::*  :**:***:.**. *.** ** : **:***.*:**:* ***** ********.:** 
 
TGG4            ATDAPPPTQLN---AITDARVTLGFYRN-GVPIGVVAP--------SFVYYPPGFRQILN 403 
TGG5            ATDAPPPTQPN---AITDARVTLGFYRN-GSPIGVVAS--------SFVYYPPGFRQILN 403 
1E71            AQPSPNPVNSTNHTAMMDAGAKLTYINASGHYIGPLFEKDKADSTDNIYYYPKGIYSVMD 394 
                *  :* *.: .   *: ** ..* : .  *  ** :          .: *** *: .::: 
 
TGG4            YIKDNYKNPLTYITENGVADLDLGNVTLATALADNGRIQNHCSHLSCLKCAMKDG-CNVA 462 
TGG5            YIKDNYKNPLTYITENGVADLDLGNVTLATALADNGRIQNHCSHLSCLKCAMKDG-CNVA 462 
1E71            YFKNKYYNPLIYVTENGISTP--GDENRNQSMLDYTRIDYLCSHLCFLNKVIKEKDVNVK 452 
                *:*::* *** *:****::    *: .   :: *  **:  ****. *: .:*:   **  
 
TGG4            GYFAWSLMDNYEFGNGYTLRFGMNWVNFTNPADRKEKASGKWFSKFLAK 511 
TGG5            GYFAWSLMDNYEFGNGYTLRFGMNWVNFTNPADRKEKASGKWFSKFLAK 511 
1E71            GYLAWALGDNYEFNKGFTVRFGLSYIDWNNVTDRDLKKSGQWYQSFISP 501 
                **:**:* *****.:*:*:***:.::::.* :**. * **:*:..*::  
 
 
Glutamine mutations: Q211E,  Q211A (Gln 187 in Sinapsis alba 1E71) 
Active site mutations: E418Q, E418D, E418H, E418A (Glu 409 ) 
binding of hydrophobic part of Aglycone (Allyl, Benzyl or indole group): F475A (Phe 473) 
Ascorbate/SO4 binding: S214A (Ser190 ) K218A (Arg194 ), I278A (Ile 257 ) 
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APPENDIX 3 
 
Amino acid sequence comparison of plant glycosidases 
 
TGG4            MAIPKAHYSLAVLVLLFVVVSSSQKVCNPECKAKEPFHCDNTHAFNRTGFPRNFTFGAAT 60 
TGG5            MAIPKAHYSLAVLVLLFVVVSSSQKVCNPECKAKEPFHCDNTHAFNRSGFPKNFTFGAAT 60 
1CBG            -------------------------------FKPLPISFDDFSDLNRSCFAPGFVFGTAS 29 
1E71            -------------------------DEEITCQENLPFTCGNTDALNSSSFSSDFIFGVAS 35 
                                                   *:  .:   :* : *. .* **.*: 
 
TGG4            SAYQIEGAAHRALNG---WDYFTHRYPEKVP-DRSSGDLACDSYDLYKDDVKLLKRMNVQ 116 
TGG5            SAYQIEGAAHRALNG---WDYFTHRYPEKVP-DRSSADLACDSYDLYKDDVKLLKRMNVQ 116 
1CBG            SAFQYEGAAFEDGKGPSIWDTFTHKYPEKIK-DRTNGDVAIDEYHRYKEDIGIMKDMNLD 88 
1E71            SAYQIEGTIGRGLNI---WDGFTHRYPNKSGPDHGNGDTTCDSFSYWQKDIDVLDELNAT 92 
                **:* **:  .  :    ** ***:**:*   *: ..* : *.:  ::.*: ::. :*   
 
TGG4            AYRLSIAWSRVLPKGRLTGGVDENGITYYNNLINELKANGIEPYVTIFHWDVPQTLEDEY 176 
TGG5            AYRLSIAWSRVLPKGRLTGGVDENGITYYNNLINELKANGIEPYVTIFHWDVPQTLEDEY 176 
1CBG            AYRFSISWPRVLPKGKLSGGVNREGINYYNNLINEVLANGMQPYVTLFHWDVPQALEDEY 148 
1E71            GYRFSIAWSRIIPRGKRSRGVNEKGIDYYHGLISGLIKKGITPFVTLFHWDLPQTLQDEY 152 
                .**:**:*.*::*:*: : **:.:** **:.**. :  :*: *:**:****:**:*:*** 
 
TGG4            GGFLSTRIVEDYTNYAELLFQRFGDRVKFWITLNQPFSLATKGYGDGSYPPGRCTG---- 232 
TGG5            GGFLSTRIVEDYTNYAELLFQRFGDRVKFWITLNQPLSLALKGYGNGSYPPGRCTG---- 232 
1CBG            RGFLGRNIVDDFRDYAELCFKEFGDRVKHWITLNEPWGVSMNAYAYGTFAPGRCSDWLKL 208 
1E71            EGFLDPQIIDDFKDYADLCFEEFGDSVKYWLTINQLYSVPTRGYGSALDAPGRCSPTVDP 212 
                 ***. .*::*: :**:* *:.*** **.*:*:*:  .:. ..*. .  .****:      
 
TGG4            CELGGDSGVEPYTVAHNQLLAHAKTVSLYRKRYQKFQGGKIGTTLIGRWFAPLNEFSELD 292 
TGG5            CELGGDSGVEPYTVAHNQLLAHAKTVSLYRKRYQKFQGGKIGTTLIGRWFVPLNEFSELD 292 
1CBG            NCTGGDSGREPYLAAHYQLLAHAAAARLYKTKYQASQNGIIGITLVSHWFEPASK-EKAD 267 
1E71            SCYAGNSSTEPYIVAHHQLLAHAKVVDLYRKNYTH-QGGKIGPTMITRWFLPYNDTDRHS 271 
                   .*:*. *** .** ****** .. **:..*   *.* ** *:: :** * .. .. . 
 
TGG4            KAAAKRAFDFFVGWFLDPLVYGKYPTIMREMVGDRLPEFTPEQSALVKGSLDFLGLNYYV 352 
TGG5            KAAAKRAFDFFVGWFLDPLVYGKYPTIMREMVGDRLPEFTPEESALVKGSLDFLGLNYYV 352 
1CBG            VDAAKRGLDFMLGWFMHPLTKGRYPESMRYLVRKRLPKFSTEESKELTGSFDFLGLNYYS 327 
1E71            IAATERMKEFFLGWFMGPLTNGTYPQIMIDTVGERLPSFSPEESNLVKGSYDFLGLNYYF 331 
                  *::*  :*::***: **. * **  *   * .***.*:.*:*  :.** ********  
 
TGG4            TQYATDAP---PPTQLNAITDARVTLGFYRN-GVPIGVVAPS--------FVYYPPGFRQ 400 
TGG5            SQYATDAP---PPTQPNAITDARVTLGFYRN-GSPIGVVASS--------FVYYPPGFRQ 400 
1CBG            SYYAAKAPR-IPNARPAIQTDSLINATFEHN-GKPLGPMAASS------WLCIYPQGIRK 379 
1E71            TQYAQPSPNPVNSTNHTAMMDAGAKLTYINASGHYIGPLFEKDKADSTDNIYYYPKGIYS 391 
                : **  :*     :.     *:  .  : .  *  :* :  .        :  ** *: . 
 
TGG4            ILNYIKDNYKNPLTYITENGVADLDLGNVTLATALADNGRIQNHCSHLSCLKCAMKDG-C 459 
TGG5            ILNYIKDNYKNPLTYITENGVADLDLGNVTLATALADNGRIQNHCSHLSCLKCAMKDG-C 459 
1CBG            LLLYVKNHYNNPVIYITENGRNEFNDPTLSLQESLLDTPRIDYYYRHLYYVLTAIGDG-V 438 
1E71            VMDYFKNKYYNPLIYVTENGIS--TPGDENRNQSMLDYTRIDYLCSHLCFLNKVIKEKDV 449 
                :: *.*::* **: *:****         .   :: *  **:    **  :  .: :    
 
TGG4            NVAGYFAWSLMDNYEFGNGYTLRFGMNWVNFTNPADRKEKASGKWFSKFLAK 511 
TGG5            NVAGYFAWSLMDNYEFGNGYTLRFGMNWVNFTNPADRKEKASGKWFSKFLAK 511 
1CBG            NVKGYFAWSLFDNMEWDSGYTVRFGLVFVDFKNNLKRHPKLSAHWFKSFLKK 490 
1E71            NVKGYLAWALGDNYEFNKGFTVRFGLSYIDWNNVTDRDLKKSGQWYQSFISP 501 
                ** **:**:* ** *:..*:*:***: ::::.*  .*. * *.:*:..*:   
Active site 
Glutamine 
Substrate binding 
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APPENDIX 4 
 
Graphs displaying enzyme activity towards sinigrin as substrate with different concentrations of 
ascorbate             
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